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Résumé 
L’approvisionnement en cholestérol est un facteur limitant la stéroïdogenèse ovarienne. 
Pour cette raison, la majorité du cholestérol requis pour la synthèse des stéroïdes est importé de 
la circulation via les récepteurs des lipoprotéines de haute (HDL) et de basse densité (LDL) 
nommés scavenger receptor (SR-BI) et low-density lipoprotein receptor (LDLr). L’ARN 
messager de SR-BI est exprimé dans les ovaires de porcs durant toutes les étapes de la 
folliculogenèse ainsi que dans le corps jaune (CL). L’expression de la protéine SR-BI a 
également été détectée dans les follicules de souris lors du cycle œstral. Chez les deux espèces, 
l’expression est concentrée dans le cytoplasme et en périphérie des cellules du follicule. Les 
gonadotrophines induisent l'expression de SR-BI dans les cellules de la granulosa porcines, avec 
une expression cytoplasmique qui augmente durant la période périovulatoire, et avec une 
migration aux périphéries cellulaires durant la maturation du CL. Une conformation de 82 kDa 
de SR-BI est fortement exprimée dans le CL porcin, avec une conformation moins abondante de 
57 kDa. Les différences entre les conformations sont attribuables à la glycosylation. La culture in 
vitro de follicules porcins avec des gonatrophines chorioniques humaines (hCG) a induit une 
hausse de régulation dépendante du temps du SR-BI de 82 kDa dans les cellules du granulosa. 
SR-BI et LDLr ont été exprimés réciproquement, avec LDLr étant le plus élévé dans les cellules 
folliculaires du granulosa et diminuant précipitamment avec la formation du CL. Pour explorer 
plus en détail les mécanismes d’approvisionnement en cholestérol de la stéroïdogenèse 
ovarienne, nous avons examiné des souris soumis à un traitement de désaccouplement de 
l'ovulation, et des souris portant la mutation nulle du gène Scarb1 (SR-BI-/-). Les résultats ont 
démontré que des ovocytes enfermés dans des structures lutéinisées expriment SR-BI. Les souris 
SR-BI-/ - présentaient de petits CLs, et de large  follicules avec des cellules de thèque 
hypertrophiées et des kystes folliculaires avec des cavités remplies de sang et une diminution de 
50% du niveau de progestérone dans le sérum. Les souris SR-BI-/ - traitées avec une combinaison 
de 20 μg / g de mevinoline et 100 μ g / g  de chloroquine ont démontré une diminution de 43% 
du niveau de progestérone sérique chez le type sauvage et de 30% chez les souris SR-BI-/ -. 
L’expression protéique de l’enzyme limitant pour la synthèse du cholestérol, 3-hydroxy-3-
methyl-glutaryl-CoA reductase (HMGR), a augmenté chez les souris SR-BI-/-. Nous avons 
présenté des preuves démontrant que les cellules des follicules expriment le SR-BI durant la 
  
iv
stéroïdogenèse et que la lutéinisation augmente l’expression de SR-BI. La maturation post-
transcriptionelle est caractérisée par la glycosylation. Sous des conditions normales, l’expression 
de LDLr est arrêtée durant la lutéinisation. Ainsi SR-BI devient le facteur principal pour 
l’importation du  cholestérol extracellulaire. En plus, la perturbation extracellulaire du 
cholestérol synthétisé de novo et l’absorption par les LDLr  chez les souris SR-BI-/- diminuent la 
fonction lutéal. L’homéostasie du cholestérol ovarien est très importante pour une lutéinisation 
adéquate et sa perturbation mène à une réduction, mais non à un blocage complet, de la fonction 
lutéal. En conclusion, l’expression de SR-BI est un facteur important, mais non essentiel, pour 
maintenir l’homéostasie du cholestérol ovarien et la synthèse des stéroïdes, et la lutéinisation. Un 
réseau de mécanismes complémentaires et compensatoires d’approvisionnement en cholestérol 
agit en concert pour assurer la synthèse des stéroïdes ovariens. 
 
Mots-clés: 
Ovaire, follicule, corps jaune, cholestérol, SR-BI, Récepteurs de lipoprotéines. 
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Abstract 
 Ovarian cholesterol supply is rate limiting to ovarian steroidogenesis.  For this reason, the 
majority of cholesterol required for steroid synthesis is imported via scavenger receptor-BI (SR-
BI) and the low-density lipoprotein (LDL) receptor from circulating HDL and LDL. SR-BI 
mRNA is expressed in pig ovaries at all stages of folliculogenesis and in the corpus luteum (CL). 
SR-BI protein expression in mouse ovary during estrous cycle was also detected. In both species, 
expression is concentrated in cytoplasm and periphery of follicular cells.  Gonadotropins induce 
SR-BI expression in pig granulosa cells, with cytoplasmic expression increasing through the 
periovulatory period, with migration to the cell periphery as the CL matured.  An 82-kDa form of 
SR-BI is strongly expressed in the pig CL, with the less abundant 57-kDa form,  differences 
between forms are attributable to glycosylation.  In vitro culture of pig follicles with human 
chorionic gonadotropin (hCG) induced time-dependent upregulation of 82-kDa SR-BI in 
granulosa cells. SR-BI and LDL receptor were reciprocally expressed, with the latter highest in 
follicular granulosa cells, declining precipitously with CL formation.  To further explore 
mechanisms of cholesterol supply to ovarian steroidogenesis, we examined mice treated to 
uncouple ovulation and mice bearing null mutation of the Scarb1 gene (SR-BI-/-). Results show 
entrapped oocytes in luteinized structures expressed SR-BI.  SR-BI-/- mice displayed small 
corpora lutea, large follicles with theca cells hypertrophied, follicular cysts with blood filled 
cavities and 50% decreased in plasma progesterone. In SR-BI-/- mice, treatment with a 
combination of 20 μg/g of mevinolin and 100 μg/g of chloroquine (CHLORO) was employed to 
disturbed cholesterol sources.  Serum progesterone was reduced by 43% in wild type and 30% in 
SR-BI-/- mice.  The protein expression of the rate-limiting enzyme for cholesterol synthesis, 3-
hydroxy-3-methyl-glutaryl-CoA reductase (HMGR) increased in SR-BI-/- mice.  It was 
concluded that follicular cells express SR-BI during follicle development and luteinization 
causes upregulation of SR-BI expression.  Posttranslational maturation is characterized by 
glycosylation.  Under normal conditions expression of the LDLr (low density lipoprotein 
recepors) is extinguished during luteinization such that SR-BI becomes the principal means of 
importation of extracellular cholesterol. Further, perturbation of cholesterol de novo synthesis 
and uptake from LDLr in SR-BI-/- mice leads to a reduction of luteal function.  Ovarian 
cholesterol homeostasis is central to adequate luteinization, and its perturbation leads to 
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reduction, but not to complete impairment, of luteal function.  We conclude that SR-BI 
expression is an important but not essential factor in maintaining ovarian cholesterol 
homeostasis, steroid synthesis and luteinization. A network of complementary and compensatory 
cholesterol supply mechanisms act in concert to assure ovarian steroid synthesis. 
 
Keywords: Ovary, follicle, corpus luteum, cholesterol, SR-BI, lipoprotein receptors. 
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1. INTRODUCTION 
 
In females, the ovaries are the basis for gamete production and hormone synthesis in 
support of reproductive behavior and gestation. The events of follicular development, ovulation 
and luteinization are governed by endocrine, paracrine and autocrine factors.  In folliculogenesis, 
some follicles leave their quiescent state to grow, then to ovulate, or die as atretic follicles. The 
ovulatory follicles collapse to form an ephemeral gland, known as corpus luteum (CL) whose 
primary function is progesterone production. This hormone regulates the estrous cycle and 
maintains pregnancy.  In humans, the CL synthesizes upwards of 40 mg/day of progesterone 
(Murphy 2000). The steroidogenic luteal cells are provided with highly efficient machinery to 
maintain luteal progesterone production. Steroid production by the CL varies remarkably among 
mammalian species. In humans, monkeys and ruminants, the CL is maintained by pituitary 
derived luteinizing hormone (LH) acting principally through the cAMP/protein kinase A 
pathway (Niswender, Juengel et al. 2000).  In contrast, it is well established that prolactin and 
estradiol are critical luteotrophic hormones in rodents and rabbits acting through their respective 
receptors (Stormshak, Zelinski-Wooten et al. 1987).  The substrate for steroid hormone synthesis 
is cholesterol, derived from multiple sources.  Luteal cells can produce cholesterol de novo, this 
method  plays a minor role in the normal functioning tissue as evidenced by the low levels of 3-
hydroxy-3-methylglutaryl coenzyme A-reductase (HMG-CoA reductase), the rate-limiting 
enzyme in the cholesterol biosynthetic pathway (Gwynne and Strauss 1982).  The major 
mechanisms for cholesterol delivery to steroidogenic cells are the endocytotic pathway involving 
low density lipoprotein (LDL) and the selective uptake of cholesterol esters from high-density 
lipoprotein (HDL) (Brannian and Stouffer 1993).  SR-BI is the receptor that mediates the 
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selective uptake of cholesterol esters from HDL (Acton, Rigotti et al. 1996) and its deletion 
produces infertility and reduced lipid levels in the CL, as measured by oil red-O staining, 
suggesting a reduction in cholesterol ester storage (Trigatti, Rayburn et al. 1999).  The authors 
report that progesterone profiles were within the normal range in these animals, suggesting that 
other sources of cholesterol may have increased in these animals to correct for the absence of 
HDL delivery. 
 
Recent exploration of the influence of hepatic SR-BI on female fertility by inducing 
hepatic SR-BI expression in mice with null mutation of the SR-BI-/- gene by adenovirus 
transduction or stable transgenesis indicated that these treatments restore female fertility by 
increasing hepatic metabolism of lipids (Yesilaltay, Morales et al. 2006). Given the apparent 
compensation by alternate sources, the goal of this work was to explore the role SR-BI in ovarian 
steroidogenesis and to examine possible alternatives sources of cholesterol that maintain normal 
luteal steroidogenesis in SR-BI -/- mice. 
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2. LITERATURE REVIEW 
In this section the physiological and molecular bases of the reproductive phenomena 
regulating the presence of reproductive cyclicity in mammals are described, focusing on 
follicular development, ovulation and corpus luteum formation, events that were studied in this 
investigation.  
2.1. FOLLICLE 
2.1.1 Follicular structure 
Follicles function to provide suitable conditions to maintain oocyte development, as well 
as the source of steroid hormones.  Follicles produce other substances that act as both autocrine 
and paracrine modulators of cellular function and include peptides, proteins, glycoproteins, 
proteoglycans and growth factors whose expression varies according to reproductive and 
follicular development conditions (Murdoch, Dailey et al. 1981; Lumsden, Kelly et al. 1986; 
Richards, Hickey et al. 1987; Wise 1987; Prevost, Belanger et al. 1989).  
 
The follicle consists of two cellular compartments.   The compartment within the 
basement membrane of the follicle is known as the granulosa layer, and components of this layer 
are in direct contact with the oocyte. This layer varies in the number and size of the cells 
according to the hormonal characteristics (Richards, Jahnsen et al. 1987; Burke, Cardenas et al. 
2005) and with the stage of follicular development. For example granulosa cells are flattened in 
primordial follicles, and this form changes to polyhedral or cubical in primary follicles (Braw- 
Tal 2002).  During early phases of follicular development, the surrounding stromal cells begin to 
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aggregate concentrically around the follicular basal lamina and form the theca layer (Motta, 
Makabe et al. 1994). Communication between the two types of follicular cells has been observed 
in numerous in vivo and in vitro experimental paradigms (Tajima, Orisaka et al. 2006). Despite 
of the joint function of the follicular cells, for this review they are described separately.  
 
2.1.2 Granulosa cells 
As mentioned before, granulosa cells form a continuous layer surrounding the oocyte and 
can be divided into different subpopulations, based on morphology and response to hormonal 
stimuli (Redmer, Kirsch et al. 1991). These cells display high proliferative capacity.  The corona 
radiata cells maintain an intimate contact and provide nutrients to the oocyte. The cumulus 
oophorus cells support and integrate the oocyte within the follicle, and contribute during the final 
stage to oocyte maturation, and serve as a barrier to sperm penetration prior to fertilization. The 
majority of the granulosa cells are known as mural cells, and these populate the follicular cavity 
with their most basal layer maintaining close contact with the basal membrane (Motlik, Fulka et 
al. 1986; McGregor, Flaherty et al. 1989).  
 
Granulosa cell proliferation varies according to their localization, to the estrous cycle 
stage and to the follicular development phase. Proliferation in granulosa cells evaluated by 
thymidine incorporation showed more elevated proliferative activity in cumulus oophorus cells 
relative to mural granulosa cells (Khamsi and Roberge 2001). Some data suggest that cumulus 
granulosa cells continue to proliferate for up to 10 h after an ovulatory stimulus, with evidence 
that cyclin E protein increases after hCG, and there was a tendency of initial decline followed by 
a transient increase in Cdk2 protein activity 8 h after hCG (Cannon, Cherian-Shaw et al. 2005). 
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Proliferation is maintained in granulosa cells in the proximity of the oocyte during ovulation of 
the rat follicle (Cannon, Cherian-Shaw et al. 2005). Observations with electronic microscopy of 
granulosa cells in co-culture have allowed observation of the morphology and content of cellular 
elements characteristic of steroidogenic and mitotically active cells (Nottola, Heyn et al. 2006).  
 
2.1.3 Theca cells 
The theca layer consists of an internal and external theca. In species as rodents, a special 
group of cells named interstitial cells capable of steroid production differentiate from the internal 
theca (Brook and Clarke 1989). This differentiation of theca is an important physiological event 
occurring during early follicular development and, apparently the theca cell layer develops from 
stromal cells and is regulated by granulosa cells (Orisaka, Tajima et al. 2006). 
 
The internal theca cell layer consists of undifferentiated fibroblast cells, blood vessels, 
and cholinergic as well as adrenergic nerve fibers. The structure of these cells is characterized by 
their elevated concentration of smooth endoplasmic reticulum as well as tubular crest 
mitochondria, characteristic of active steroidogenic cells (Motta, Nottola et al. 1995).  The 
vascularization of these cells increases as the follicle develops (Macchiarelli, Vizza et al. 1992).  
Studies on follicular vasculature showed that large vessels are located in the outer theca layer, 
while smaller vessels are observed neighboring the inner layer, close to the basal membrane  
(Augustin, Braun et al. 1995; Redmer, Doraiswamy et al. 2001; Feranil, Isobe et al. 2004). The 
theca is the source of vascularization of the avascular granulosa cells during luteinization. The 
increase in blood vessels is a response to angiogenic factors including vascular endothelial 
growth factor (VEGF), angiopoietins 1 and 2 (Ang-1 and Ang-2) and endocrine gland VEGF 
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(EG-VEGF) originating from the granulosa cells, and regulated by LH (Phan, Rakenius et al. 
2006, for review see Fraser 2006). 
 
Within growing follicles, theca cells are stimulated by LH to synthesize androgens that 
serve as substrate for estrogen synthesis in granulosa cells.  There is evidence in ruminants that, 
after ovulation, theca cells are transformed into the small luteal cells of the corpus luteum (Alila 
and Hansel 1984; O'Shea 1987) and granulosa cells are believed to be transformed in large luteal 
cells (Alila and Hansel 1984) but this issue has not been definitively resolved.  
 
2.1.4 Follicular development 
The ovary is a primary functional organ of the female reproductive system, and it plays 
two major physiological roles. First, the ovary is responsible for the differentiation and release of 
mature oocytes for fertilization (McGee and Hsueh 2000). Second, it is responsible for 
synthesizing and secreting hormones that are essential for follicle development, menstrual and 
estrous cyclicity and maintenance of the reproductive tract and its function (Hirshfield 1991).  
 
Ovarian follicle development is a complex process that begins with the establishment of 
primordial follicle, after birth, depending on the species in a process that involves apoptosis of 
some of the oocytes and initiation of meiotic division of some others (Gomperts, Garcia-Castro 
et al. 1994; Pepling and Spradling 1998). The surviving oocytes become enveloped by somatic 
cells, thereby producing primordial follicles considered to be in a ‘‘quiescent’’ state, since no 
major morphological changes take place until they enter the pool of growing follicles (Zamboni, 
Thompson et al. 1972). The resting follicle is a round structure with a diplotene oocyte 
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surrounded by a single layer of flattened follicular cells (Pepling and Spradling 2001). The 
primordial follicle population present at birth has long been believed to be predetermined, 
following a log-linear rate of decline during the reproductive life (Miller, Charleston et al. 1999). 
Although this idea has recently been challenged (Johnson, Canning et al. 2004; Johnson, Bagley 
et al. 2005), the weight of the evidence argues against postnatal oogenesis in mammals. Several 
studies of gene mutation, particularly knockin and knockout mice, have elucidated the 
importance of genes that control differentiation of germ cells that culminate in alteration of 
primordial follicular development. Examples of these are the Dazla gene (Ruggiu, Speed et al. 
1997; McNeilly, Saunders et al. 2000), the factor in the germline alpha (Figla) (Soyal, Amleh et 
al. 2000), the nerve growth factor (Ngf ) and others (Dissen, Romero et al. 2001). 
 
Recruitment of primordial follicles into the growing pool begins the coordinated and 
interdependent development of the somatic and germ cell components of the ovarian follicle. The 
end of reproductive life, or ovarian senescence, occurs when this pool of primordial follicles is 
depleted by death or through growth, followed by subsequent ovulation and/or atresia (Hirshfield 
1991). Although some primordial follicles will be stimulated to grow immediately, the majority 
will remain dormant, perhaps because of autocrine or paracrine inhibition, until they receive 
signals to enter the growing pool (McGee and Hsueh 2000). The follicle that is recruited from the 
pool of resting follicles to enter the growth phase is termed primary follicle.  The primary follicle 
enlarges because of an increase in size of the oocyte (Baca and Zamboni 1967; Zamboni 1974; 
Motta, Makabe et al. 1994), and conversion of the squamous or flattened granulosa cells into 
cuboidal granulosa cells (Hirshfield 1991). Another characteristic of the primary follicle is the 
formation of a zona pellucida, which surrounds the oocyte and is maintained throughout growth 
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until the oocyte is ovulated (Rankin, Familari et al. 1996; Rankin, Talbot et al. 1999; Rankin, 
O'Brien et al. 2001).  The follicular cells are still arranged in a single layer to surround the oocyte 
and still changing shape to polyhedral or cubical. In parallel, beginning with the early phases of 
follicular development, the surrounding stromal cells start to aggregate concentrically around the 
follicular basal lamina and on time form the theca cells layer (Zamboni 1974; Motta, Makabe et 
al. 1994). 
  
Conversion of primordial into primary follicles involves participation of genes and 
proteins that regulate organization of zona pellucida by synthesis of the extracellular zona 
pellucida proteins ZP1, ZP2 and ZP3 (Rankin, Talbot et al. 1999). Mice Zp1–/– have loosely 
organized zonae pellucidae and reduced litter sizes. Zp2–/– and Zp3–/– mice are sterile (Rankin, 
Familari et al. 1996; Rankin, O'Brien et al. 2001). 
 
Forkhead genes have also been shown to play a role in folliculogenesis at the primary 
follicle stage. In Foxl2–/– ovaries, granulosa cell differentiation is blocked at the squamous to the 
cuboidal transition (Schmidt, Ovitt et al. 2004). Foxo3a ovaries have a tremendous increase in 
the number of early growing follicles with enlarged oocytes (Castrillon, Miao et al. 2003).  
By the time that the follicle reaches the pre-antral stage, granulosa cells have proliferated 
to form multiple layers.  In addition, the pre-antral follicle acquires an outer layer of thecal cells 
separated from the follicle by the basal lamina (van den Hurk and Zhao 2005).  At the end of this 
stage, the pre-antral follicle has several layers of granulosa cells and has acquired an extensive 
network of gap junctions (Hirshfield 1991). These junctions are intercellular membrane channels 
that allow nutrients, inorganic ions, second messengers and small metabolites to pass from cell to 
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cell (Kidder and Mhawi 2002).  The next step in the developmental sequence is formation of the 
antral cavity with fluid rich in water, electrolytes, serum proteins and with high concentrations of 
steroid hormones secreted by the granulosa cells (Hirshfield 1991).   In some species, antral 
cavity formation is not accompanied by notable changes in oocyte morphology, while in others, 
the oocyte continues to expand during the early antral phase of development (van den Hurk and 
Zhao 2005). At the antral stage, most of the follicles will undergo atresia, whereas the remaining 
antral follicles will survive under the influence of FSH and grow to the pre-ovulatory stage 
(Hirshfield 1991). Factors such as the aryl hydrocarbon receptor (Ahr) and superoxide dismutase 
(SOD) have been shown to regulate follicular growth to the antral stage  (Gupta RK 2006 ). The 
Ahr is a ligand-activated transcription factor that functions in mediating the toxicity of various 
contaminants (Pocar, Fischer et al. 2005).  Without this gene, there is a decrease in the number of 
antral follicles and reduced fertility (Benedict, Lin et al. 2000; Benedict, Miller et al. 2003). 
 
The follicles that survive the massive atresia visited on the preantral and early antral 
population acquire the capacity to produce estrogen and grow to the pre-ovulatory stage 
(Hirshfield 1991). They exhibit elevated estradiol concentration, higher granulosa cell number, 
and elevated LH binding capacity in comparison to non-estrogenic follicles (Ireland and Roche 
1983). The pre-ovulatory follicle is capable of releasing the oocyte for fertilization, upon 
stimulation by LH (McGee and Hsueh 2000). Rupture of follicle basement membrane during 
ovulation is controlled by several different genes and proteins described in ovulation section 
(below). After the oocyte is released for fertilization, the remaining theca and granulosa cells 
differentiate into the CL (Hirshfield 1991; Elvin and Matzuk 1998; McGee and Hsueh 2000)  
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Folliculogenesis consists of two phases: The first, considered independent of 
gonadotropin influence, also called basal folliculogenesis, includes the passage from primordial 
follicle to primary follicle, and is regulated by growth factors. The second, gonadotropin 
dependent phase, includes follicle development to ovulation, and is also known as tonic 
folliculogenesis (Peluso, Luttmer et al. 1984; Hillier 1994). Follicular development is highly 
heterogeneous, due to the fact that follicles of the same size develop at different rates throughout 
the estrous cycle (Rajakoski 1960; Matton, Adelakoun et al. 1981; Driancourt, Thatcher et al. 
1991). 
 
In the complexity of follicular development, recruitment, selection and dominance also 
need to be considered (Matton, Adelakoun et al. 1981; Hodgen 1982; Goodman and Hodgen 
1983).  Recruitment considered as independent of gonadotropins, in which a group of follicles 
initiates growth and acquires the capacity to respond to gonadotropins.  The follicles then depend 
on gonadotrophin support to continue its development; until reaching a preovulatory size 
(Fortune 1994).  At this stage of follicular development not only is gonadotropic action (mainly 
FSH) necessary but there are also autocrine or paracrine influences, e.g growth factors such as 
epidermal growth factor (EGF; Dorrington, Bendell et al. 1987; Richards, Russell et al. 2002; 
Kaczmarek, Schams et al. 2005). Selection is the process by which few follicles, from the total 
recruited population, escape atresia and continue their development.  Dominance is when one or 
more follicles are selected to undergo ovulation.  Dominance may involve interference with 
follicles in less advanced development in the cohort of the recruited follicles, reducing their FSH 
support (Thatcher, Driancourt et al. 1991).  This effect has been attributed to the secretion of 
estradiol and inhibin A, coming from the more developed follicles (Andersen and Byskoy 2006) 
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Specifically, inhibin and estradiol block FSH and favor the increase of LH receptor first in theca 
cells of tertiary follicles (McNatty, Fidler et al. 2000), an action that is inhibited by progesterone 
administration. Apparently, the inhibin-estrogen synergism favors LH receptors in granulosa 
cells  and reduce FSH receptors in a feedback process  (Lisk 1964; Ramirez, Abrams et al. 1964; 
Williams and Lipner 1981; Kaneko, Noguchi et al. 2002; Martin, Fogwell et al. 1991; Medan, 
Nambo et al. 2004; Pak, Chung et al. 2006) It is possible that the selection also occurs in 
response to the reduced response of small follicles to the FSH stimuli (Driancourt, Thatcher et al. 
1991; Driancourt, Webb et al. 1991). Dominance is the mechanism by which one or two follicles 
(several in mice and pigs) are rescued from atresia (Hodgen 1982). In this process it is 
considered that the “dominant” follicle becomes hypersensitive to FSH action, which is regulated 
by autocrine and paracrine factors, such as insulin like growth factor-I (IGF-I) action, (Eden, 
Jones et al. 1988; Behl and Kaul 2002). Recently Murayama and co-workers suggested that 
insulin itself may support the maturation of preovulatory follicles and the insulin-induced 
increase in growth hormone receptor (GHR)  in dominant follicles may be a turning point for 
follicles to enter the preovulatory phase during final follicular development (Shimizu, Murayama 
et al. 2008). 
 
Differences among species exist. In most domestic animals, two or three waves of 
follicular activity occur during the estrous cycle (Rajakoski 1960; Savio, Keenan et al. 1988; 
Fortune 1994). In cattle the first wave has been identified at day 0 (ovulation day) and the second 
at day 10. During the first wave, the recruitment of several follicles has been observed, but only 
one reaches the dominant stage, initiating its regression at day 11 of the estrous cycle, this wave 
is known as non-ovulatory.  As in the first wave, second wave is characterized by a varied 
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number of follicles that initiated to grow, nevertheless, only one becomes dominant and proceeds 
to ovulation, (for review Ireland, Mihm et al. 2000).   
 
3. OVULATION 
 
Ovulation is the rupture of the ovarian follicle to liberate the oocyte (Espey 1980). 
Initially, this process was considered to be regulated exclusively by increased follicular pressure; 
later, the enzymatic action for collagen lysis was added (Espey 1980).  More modern concepts 
consider ovulation as a complex process whereby ovarian follicles reactivate oocyte meiosis, 
create a rupture pore in the apical follicle wall and initiate tissue restructuring and differentiation 
to form the CL (Russell and Robker 2007). This complex process is controlled by synchronous 
participation of endocrine hormones, as well as autocrine, paracrine and intracrine mechanisms 
from the oocyte, theca, mural and cumulus granulosa cells.  
 
Preovulatory follicles contain two distinct sublineages of granulosa cells with highly 
different responses to gonadotropin action. Mural granulosa cells respond to LH surge due to 
greater receptor levels abundance relative to cumulus cells (Peng, Hsueh et al. 1991). Comparing 
follicle cell contents of LH receptors, theca cells express the highest quantity, while in mural and 
cumulus granulosa cells LH receptors increase during and after ovulation (Bukovsky, Chen et al. 
1993; Goudet, Belin et al. 1999; Robert, Gagne et al. 2003). 
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The LH surge stimulates G protein-coupled receptors within the plasma membrane of 
cells in the ovarian follicles, and signals of adenylyl cyclase appear, increasing cyclic adenosine 
monophosphate (cAMP) which in turns regulates protein kinase A (PKA) (Richards 2001). After 
the PKA catalytic unit is activated its moves to the nucleus, where it phosphorylates a number of 
transcription factors such as CREB (Mukherjee, Park-Sarge et al. 1996; Yazawa, Mizutani et al. 
2003). The interaction of phosphorylated CREB with the coactivator CREB-binding protein 
stimulates the expression of gonadotropin/ CRE-regulated ovarian genes (Mukherjee, Park-Sarge 
et al. 1996). This process is temporally associated with immediate transcriptional regulation of 
numerous genes, and is presumed to be involved in the synthesis and/or activation of specific 
proteases that degrade the follicle wall (Ohnishi, Ohnishi et al. 2005). 
 
In recent years, molecular and transgenic techniques have allowed the integration of 
gonadotropin-regulated effects, steroids and prostanoids that regulate the complex gene cascade 
that produces ovulation (Robker, Russell et al. 2000; Richards, Russell et al. 2002).  
 
3.1 Role of the granulosa layer during ovulation 
 There is extensive information about the changes occurring in the granulosa and theca 
cells during ovulation as well as the role of other follicular tissues,  the oocyte and related 
epithelial, endothelial and connective tissues. Although some changes have their origin within 
the theca cell layer, or simultaneously within the theca and granulosa layers, the granulosa cell 
layer undergoes the greater alteration during ovulation, displaying changes as soon as the LH 
surge occurs, some of these initial changes include activation of the genes taking part in the 
inflammation, ovulation and cell remodeling processes (Espey 1980). 
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Within follicular tissue, one enzyme for which transcription is upregulated during the 
early stages of the ovulatory process is 5-aminolevulinate synthase (ALAS). ALAS increases 
within the granulosa layer as soon as 30 min after hCG, and declines once the mature ovarian 
follicles start to rupture (Espey 2006).  ALAS expression is involved during the acute 
inflammatory phase response, one of the characteristics during ovulation, which is an abundance 
of overlapping pathways activated by tissue damage (Ferreira and Gong 1995; Lentsch and Ward 
2000). ALAS has been associated with cytochrome P450scc during steroid metabolism. Also 
ALAS expression within the corpora lutea as it develops from the ruptured follicles is 
significant. 
Initial changes during the first minutes after LH include the induction of genes for early 
growth response protein-1 (Egr-1) (Russell, Doyle et al. 2003). Egr-1 is a transcription factor that 
promotes expression of numerous genes important in inflammation, vascular hyperpermeability, 
hypoxia, coagulation, and other events associated with tissue damage (Espey, Ujioka et al. 2000; 
Yan, Fujita et al. 2000; Yan, Lu et al. 2000; Silverman, De Sanctis et al. 2001).  In the mouse, 
Egr-1 mRNA increases in the granulosa layer within 30 min after hCG application, reaches a 
peak from 2-4 h, remains moderately elevated through 12 h after application, and declines 24 
after hCG application (Espey, Ujioka et al. 2000; Russell, Doyle et al. 2003). On the other hand, 
epiregulin, a member of the epidermal growth factor (EGF) family, has been associated with 
Egr-1 mRNA expression, as well as with increases of  cyclooxygenase 2 (COX-2) mRNA and 
protein expression (Sasaki, Pai et al. 1998). It has been observed that epiregulin expression 
presents irregular and temporal expression patterns (Sasaki, Pai et al. 1998; Shirakata, 
Komurasaki et al. 2000). 
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  COX-2, the key enzyme for prostaglandin synthesis is a component of the ovulatory 
process (Richards, Russell et al. 1998). COX-2 plays a functional role in cumulus cell expansion 
and it is induced during the inflammation process, (Sirois and Richards 1993; Williams and 
DuBois 1996; Song, Sirois et al. 1998). COX-2 null mice do not ovulate (Morham, Langenbach 
et al. 1995); and cumulus cells do not expand, (Davis, Lennard et al. 1999).  In the mouse, COX-
2 mRNA, confined to the granulosa layer of the mature follicles, increases 4 h, and declines 8 h 
after hCG application, (Richards, Russell et al. 1998; Davis, Lennard et al. 1999; Joyce, Pendola 
et al. 2001).  In vitro granulosa cells express COX-2 and VEGF (vascular endothelial growth 
factor) after stimulation with recombinant adiponectin involving MAPK pathway, indicating that 
these molecules act to produce tissue remodeling (Ledoux, Campos et al. 2006). 
 
The inflammatory process characterizing ovulation is followed by the imminent elevation 
of toxic products, which must be neutralized (Buetler 1998). Hence, the granulosa cells trigger 
the expression of genes such as: g-glutamylcysteine synthetase (GCS), GCS mRNA is 
distributed within the mature follicle granulosa layer, even before hCG administration (Clague, 
Sevcik et al. 1992; Jarrell, Sevcik et al. 1992). GCS expression increases with hCG 
administration in mural granulosa cells, also, hCG permits the expression in theca interna that 
surrounding the granulosa cells. GCS expression is elevated between 4 and 8 h after hCG 
application, specifically in the theca tissue as well as in some localized areas of the ovarian 
stroma. GCS is a metalloprotein that serves as the rate limiting enzyme for synthesis of 
glutathione. Glutathione is a tripeptide that protects cells against oxidative stress during the acute 
inflammatory reactions and other conditions promoting cellular damage (Clague, Sevcik et al. 
1992; Buetler 1998; Soltaninassab, Sekhar et al. 2000). 
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Also in mice at 4-8 h after hCG, tumor necrosis factor-stimulated gene-6 (TSG-6) is up-
regulated in granulosa cells and goes throughout granulosa cumulus cells 12h after hCG 
(Yoshioka, Ochsner et al. 2000). TSG-6 is a common component of inflammatory reactions, and 
may exert a negative feedback action by neutralizing hyaluronan-induced inflammatory stress on 
the extracellular matrix of the cumulus cell-oocyte complex, during the ovulatory process (Fulop, 
Kamath et al. 1997; Yoshioka, Ochsner et al. 2000).  At the same time, but in different location, 
the regulator of G-protein signaling protein-2 (RGS2) is expressed, along the antral border of the 
mural granulosa as well as within the cumulus mass surrounding the oocyte (Ujioka, Russell et 
al. 2000). RGS2 has been characterized as a GTPase-activating protein, thought to attenuate cell 
signaling by hydrolyzing GTP to GDP (Ujioka, Russell et al. 2000).  
 
Follicular preparation for oocyte release is accompanied by changes from estradiol 
synthesis to acute progesterone synthesis, requiring the presence of genes involved in the 
steroidogenesic process as progesterone progesterone receptors (PR) presence and activity, 
(Robker, Russell et al. 2000). Progesterone action in ovary regulates follicular granulosa cells 
during ovulation by increasing its levels and by decreasing in estradiol levels, regulating mitotic 
or apoptotic activities. Other progesterone actions are regulated by membrane progesterone 
receptors that decrease cAMP with subsequent inhibition of mitosis (Peluso 2006). Progesterone 
action during ovulation has been clarified using progesterone receptor null mice that display CL 
formation with no follicular rupture (Lydon, DeMayo et al. 1995). In addition, anovulation in 
progesterone receptor null mice has been related with decrease in ADAMTS and cathepsin L, 
both regulated by FSH and LH in a PR-dependent manner (Robker, Russell et al. 2000).  
ADAMTS is a protein with strong proteolytic effects and believed to act in follicular wall 
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degradation, while cathepsin L is a papain family also with proteolytic effects (Robker, Russell 
et al. 2000). Another element is endothelin which is  expressed in granulosa cells and decreases 
in animals with blockage in progesterone receptors (Palanisamy, Cheon et al. 2006). 
 
A rate limiting factor in steroidogenic activity is maintained is transport of cholesterol 
into mitochondria by StAR (Ronen-Fuhrmann, Timberg et al. 1998; Chaffin, Dissen et al. 2000). 
It is coexpressed with adrenodoxin, whose transcript, increases significantly in granulosa cells 4 
h after hCG administration, and continues in postovulatory luteinized tissue (Espey and Richards 
2002). Adrenodoxin and StAR are also are co-expressed with cytochrome P450scc (Rodgers, 
Lavranos et al. 1995; Grinberg, Hannemann et al. 2000; Muller, Lapko et al. 2001). StAR 
mRNA has an initial peak after hCG and a second higher peak once the corpora lutea are 
synthesizing substantial amounts of progesterone (Ronen-Fuhrmann, Timberg et al. 1998; 
Chaffin, Dissen et al. 2000). 
 
 The presence of 3α-hydroxysteroid dehydrogenase (3α-HSD) is necessary to catalyze 
the oxydoreductive processes during steroid production (Penning, Pawlowski et al. 1996; Ma and 
Penning 1999).  In rats, 3α-HSD mRNA is detectable within theca interna cells of mature 
follicles before hCG stimulation, and the protein is translocated to the granulosa layer 2 h after 
hCG application and continues to be elevated until 8 h after hCG application, declining 
thereafter, although a limited amount still remains within luteal tissue (Penning, Pawlowski et al. 
1996; Espey, Yoshioka et al. 2001; Espey and Richards 2002).  
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Ovulation requires degradation of follicular wall by the action of proteolytic enzymes that 
include disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS-1) and 
cathepsin L for proteolysis of extracellular matrix (Robker, Russell et al. 2000). ADAMTS-1 
which increase significantly in the granulosa layer by 4 h after hCG application and reaches a 
peak at12 h after hCG application (Espey, Yoshioka et al. 2000), at the time when rat follicles 
begin to rupture. ADAMTS-1 transcription depends on the usual increase in ovarian 
progesterone synthesis and on the up-regulation of ovarian progesterone receptor during 
ovulation (Doyle, Russell et al. 2004; Porter, Clark et al. 2005; Shozu, Minami et al. 2005). 
Cathepsin L is induced in granulosa cells of growing follicle by FSH, but the highest levels of 
cathepsin L mRNA occur in preovulatory follicles in response to LH (Robker, Russell et al. 
2000). 
 
3.2 Role of theca the layer during ovulation 
As mentioned previously, the expression of genes at the moment of the ovulation is not 
exclusive to the granulosa cell layer, as many changes occur simultaneously in theca and 
granulosa layers (Fig.1).  
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Figure 1.  Principal candidate genes involved in ovulation: They are listed according to the 
follicular compartment; ALAS= amino levulinic acid synthetase, Erg-1= , CoX-2= 
Cyclooxygenase-2, GCS= γ-glutamilcystein synthetase, epiregulin, StAR 
(steroidogenic acute regulatory protein), 3a-HSD (3-alpha-hydoxysteroid-
dehydrogenase) ADAMST-1(Disintegrin and metalloproteinase with trombospondin 
motifs), Cathepsin-L, TIMP-1 (Tissue inhibitor of metalloproteinase-1), CBR 
(Carbonyl reductase), PAP-III (Pancreatitis-associated protein-III), TSG-6 (Tumor 
necrosis factor-stimulated gene-6), RGS-2 (Regulator of G-protein signaling protein-
2) (Adapted from Ohnishi, Ohnishi et al. 2005).   
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During ovulation, theca cells express multiple matrix metalloproteinases (MMPs) 
including MMP-1, MMP2, MMP9, MMP14 AND MMP19 (Hagglund, Ny et al. 1999).  At least 
one metalloproteinase-1 inhibitor (tissue inhibitor of metalloproteinase-1 or TIMP-1) mRNA is 
expressed on a temporal pattern basis. Similar to ADAMTS-1 mRNA, it is present within both 
thecal and stromal ovarian tissue and increases at the time of ovulation (Simpson, Byers et al. 
2001).  During ovulation, TIMP-1 regulates ADAMTS-1 degradation as well as other ovarian 
metalloproteinases (Espey, Ujioka et al. 2003).  In the mouse, TIMP-1’s protective mechanism 
results in the presence of carbonyl reductase (CBR) mRNA, detectable before hCG, and with an  
increase over 2 h after hCG, reaching a peak at 8 h, and declining 24 h after hCG treatment 
(Espey, Yoshioka et al. 2000).  Its spatial distribution is mainly within thecal and stromal 
regions; however, the granulosa layer shows a little expression (Espey, Yoshioka et al. 2000).  
CBR increases during ovulation, it might function as a local protective response to the 
substantial steroid and prostanoid increases within the interstitial tissue of the ovary (Inazu and 
Fujii 1998; Espey, Yoshioka et al. 2000). 
 
 During ovulation, blood vessels degradation may be controlled by pancreatitis-associated 
protein-III mRNA (PAP-III) that is expressed 8 h after hCG administration in mice (Yoshioka, 
Fujii et al. 2002), and limited to the hilar region of the ovarian stroma. It is principally found 
within endothelial cells limiting the inner walls of blood vessels. PAP-III is a macrophage 
chemoattractant induced in and released from injured tissue (Heller, Fiedler et al. 1999). Ovarian 
PAP-III mRNA might be expressed in conjunction with a protective response to the hyperemia, 
exudation, proteolysis, and inflammation characterizing the ovulation event (Yoshioka, Fujii et 
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al. 2002; Namikawa, Okamoto et al. 2006). As previously noted, theca cell action at ovulation, 
has not been elucidated; however, Richards et al., have proposed that the theca cell layer may 
serve as protective anti-inflammatory barrier to prevent inappropriate release of oocytes 
(Richards, Russell et al. 2002). 
 
4. PROLIFERATION AND DIFFERENTIATION 
 
 During and following ovulation, changes at cell cycle activity occur and culminate with 
final cell differentiation, characterized by arrest in cellular proliferation. These changes include 
several molecular cascades within the luteal cells. For such a reason, this section attempts to 
briefly describe the aspects related to these changes, focused on cell proliferation versus cell 
differentiation. 
 
4.1 Hormonal aspects in proliferation versus differentiation 
It has been well documented that FSH and estradiol are mitogenic factors, whereas the 
LH surge terminates granulosa cell proliferation and initiates differentiation by inverting the 
action of estradiol and FSH over the positive regulators of cell cycle progression in follicular cell 
types (Richards JS 1980; Rao MC 1978). This action depends on hormones binding to specific 
receptors and activation  of the cAMP and PKA pathway (Jonassen and Richards 1980).  
Estradiol regulates cell proliferation by inducing Cyclin D1 expression as well as decreasing cdk 
inhibitor levels (Foster and Wimalasena 1996; Altucci, Addeo et al. 1997). In granulosa cells, 
estradiol induces cyclin D2 and cyclin E expression, with concurrent p27 reduction (Robker and 
Richards 1998). Other molecules regulating cell cycle include: a) activin, produced in high levels 
within preovulatory granulosa cells, has been shown to stimulate DNA synthesis (Miro and 
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Hillier 1996) b) Insulin-like growth factor-1 (IGF-1) is also implicated in granulosa cell 
proliferation (Zhou, Refuerzo et al. 1995). Studies in IGF-1 null mice showed that large antral 
follicles are present within ovaries, indicating that IGF-1 may be more important for 
differentiation than for proliferation (Baker, Hardy et al. 1996; Chaffin, Schwinof et al. 2001). 
   
4.2 Cell cycle control 
During follicular development follicular cells are highly proliferative (Rao, Midgley et al. 
1978; Hirshfield 1991), a characteristic that is diminished or lost toward luteinization (Richards, 
Hedin et al. 1986; Richards 1994). As mentioned before, estradiol activates events that favor 
proliferation (Hampl, Pachernik et al. 2000; Cannon, Cherian-Shaw et al. 2005).   Early, during 
the G1 phase, D-type cyclin activates cyclin dependent kinase 4 and 6 (cdk4 or cdk6); later, 
within G1 phase, cyclin E accumulation activates cdk2 (Koepp, et al 2001).  Progression through 
S phase is regulated by cooperation of cdk4/6 and  A/D-type cyclins with cdk2/cyclin E 
complexes  (Koff, Cross et al. 1991; Lew, Dulic et al. 1991) followed by the initiation of M 
phase by cyclin B-cdk2 complexes (Lew, et al. 1996).  The S-phase is regulated by cyclin/cdk 
binding, resulting in a complex requiring phosphorylation to activate, in turn, cellular substrate 
phosphorylation such as retinoblastoma protein (pRb) which further releases the transcription 
factor E2F, regulating DNA synthesis and gene expression  (Inaba, Matsushime et al. 1992; 
Xiong, Menninger et al. 1992; Xiong, Zhang et al. 1992; Stevaux and Dyson 2002). Cyclin D2-
null mice display impaired granulosa cell proliferation, underdeveloped ovarian follicles, and 
lack of ovulation (Sicinski, Donaher et al. 1996).  
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Arrest of the cell cycle in G1 phase with the subsequent CL formation is the result of 
inhibitors of cell cycle kinases, such as Cip/Kip (p21Cip1, p27Kip1, p57Kip2), as well as Ink4 
family, another family of cdk inhibitors (Sherr and Roberts 1999). The Cip/Kips have relatively 
broad specificity and are able to bind cdk4/6 and cdk2, enabling them to inhibit the activity of 
several kinase cascades, thereby blocking the cell cycle progression at multiple points, in 
particular at the G1 phase (Polyak, Lee et al. 1994). Both p27 and  p21Cip1, are highly expressed 
in the corpus luteum, showing slight different patterns of induction (Robker and Richards 1998). 
Loss of p27 results in impaired differentiation, as has been observed by the inability of granulosa 
cells to luteinize normally, and produce enough progesterone in order to support pregnancy 
(Fero, Rivkin et al. 1996). 
Analysis of the cell cycle regulators after application of hCG or the LH surge showed that 
cyclin D2 and p27 are regulated inversely (Robker and Richards 1998).  During luteinization, 
there is down-regulation of cyclin D2 and while p27 is up-regulated, leading to the cell cycle 
arrest at the G1 phase and at 24h of hCG addition or LH surge (Fero, Rivkin et al. 1996; 
Nakayama, Ishida et al. 1996).  Using in situ hybridization in hormone-treated-
hypophysectomized rats, it has been shown that cyclin D2 mRNA expression increases and p27 
mRNA expression decreases in granulosa cells (Uilenbroek and Richards 1979; Richards 1980). 
Specifically, in rats treated with estradiol and FSH, cyclin D2 mRNA and protein are expressed 
at high levels within granulosa cells of preovulatory follicles (Robker and Richards 1998). 
However, different types of granulosa cells display different proliferative responses: the cells 
next to the oocyte maintain their mitotic capacity beyond the beginning of luteinization (24h 
after PMSG), in comparison with mural granulosa cells (Cannon, Cherian-Shaw et al. 2005).  
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In summary, the major change observed in granulosa cells during the peri-ovulatory 
transition after gonadotropin action is cdk2 down-regulation, produced by cell cycle inhibitors 
with a consequent arrest in proliferation. 
 
5. LUTEINIZATION 
As described above, follicular cells undergo morphological and biochemical changes in 
response to the preovulatory surge of LH, resulting in formation of a transitory endocrine ovarian 
gland, the CL (Zeleznik and Somers 1999). The CL results from a final follicular cell 
differentiation, termed luteinization, with a shift in the secretion of estradiol to progesterone, an 
important regulator of the length of reproductive cycle and base for pregnancy maintenance 
(Uilenbroek 1985; Keyes and Wiltbank 1988; Zeleznik and Somers 1999; Niswender, Juengel et 
al. 2000; Murphy, Gevry et al. 2001). 
 
During CL formation, one of the major changes is the vasculization of the granulosa cells 
via elements that invade the follicle from the theca compartment (Bruce and Moor 1976). This 
invasion also carries the theca cells in a centripetal fashion, and subsequently throughout the CL 
by lateral branching of centripetal veins and arteries.  This is the mechanism by which the 
steroidogenic theca cells are dispersed throughout the corpus luteum and is a process facilitated 
by angiogenic factors (Murphy, Gevry et al. 2001).  
 
5.1 Corpus luteum structure 
The CL is a heterogeneous gland composed of small and large steroidogenic luteal cells, 
fibroblasts, endothelial, pericytes, and immune cells (Channing 1969; Channing 1969). These 
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cells have different morphological, endocrine, and biochemical features. Interactions between the 
corpus luteum cell components  are essential for the maintenance of  health and steroidogenic 
function of the CL (Nelson, McLean et al. 1992; Davis, Rueda et al. 2003; Townson and Liptak 
2003). Once luteinization takes place, a defined cell population undergoes extensive hypertrophy 
and differentiates into large steroidogenic luteal cells, whereas another cell population remains 
much smaller and comprises small steroidogenic luteal cells (Fitz, Mayan et al. 1982). The 
primate corpus luteum consists of luteinized granulosa cells, which may correspond to the large 
steroidogenic luteal cell population in other species (Murphy 2000) and comprise from 25% to 
35% of the CL’s total volume. The primate luteinized theca cells make up from 12% to 18%. 
The rest of the CL includes blood vessels 11%, connective tissue 22% to 29%, and fibroblasts 7 
to 11% (Gillim, Christensen et al. 1969; Niswender, Juengel et al. 2000; Wulff, Dickson et al. 
2001; Davis, Rueda et al. 2003).  
 
The large luteinized cells and the small luteinized cells not only differ in cell population 
number but also in structure, function and response to different hormonal stimuli (Hoyer and 
Niswender 1985). Large luteal cells possess abundant mitochondria, rough endoplasmic 
reticulum, lipid droplets, as well as secretory granules.  Large luteal cells contain oxytocin (cow 
and ewes) and relaxin (rat, pig and cow Taylor and Clark 1993; Bathgate, Moniac et al. 1999).  
In the mouse, these cells are characterized by a small round nucleus, spherical shape, and 
abundant cytoplasm (Galosy and Talamantes 1995). In the rat, large luteal cells undergo a 
dramatic increase in protein content with luteal development, a result of hypertrophy (Gillim, 
Christensen et al. 1969; Wulff, Dickson et al. 2001) . There is a concomitant increased capacity 
in the large cells to produce steroids with direct result of the enhanced expression of sterol carrier 
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protein 2 (SCP2), P450scc, adrenodoxin and adrenodoxin reductase proteins, specifically 
required to transport and process cholesterol for steroid production (McLean, Nelson et al. 1992). 
 
In contrast to large luteal cells, small luteal cells show less cytoplasm and large oval 
nuclei (Galosy and Talamantes 1995), moderate mitochondria number, greater amounts of 
smooth endoplasmic reticulum and ribosomes, minor amounts of Golgi apparatus and no lipid 
droplets and secretory grains (O'Shea, Wright et al. 1987; Kenny, Farin et al. 1989). These cells 
produce approximately 15% of the basal progesterone secreted by the CL and have LH receptors 
(O'Shea, Wright et al. 1987). 
 
In ruminants and rodents, small and large luteal cells differ in many aspects: (a) basal 
rates of progesterone secretion, with large cells producing more than 80% of the progesterone, 
(b) an absence of  LH receptors, but presence of growth hormone in large luteal cells (Lucy, 
Collier et al. 1993; Webb, Woad et al. 2002) and PGF2α receptors (Meidan, Girsh et al. 1990), 
(c) large luteal cells express cycloxygenase 2 (COX-2) in response of  PGF2α and participate in 
luteolysis (Tsai and Wiltbank 1997). 
 
5.2 Corpus luteum classification 
Classification of CL is based on a) the female reproductive condition, b) duration of CL 
or life span and c) progesterone secretion. In the first classification four CL types have been 
reported in reproductive mammals: 1) normal cycle CL, 2) pregnancy CL, 3) lactation CL, and 4) 
pseudopregnancy CL. According to its life span, CL development is divided in three phases.  In 
the growing phase, there is hypertrophy of luteal cells.  Between estrous cycle days 4-7 in the 
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cow, the corpus luteum increases in weight and size, acquiring a great capacity to react to LH, 
causing increases in progesterone secretion. (Kesler, Weston et al. 1981).  During the 
maintenance phase, progesterone is synthesized and secreted by steroidogenic cells.  During the 
regressive phase, there is morpho-physiological death of the endocrine gland (Rothchild 1981).  
Subnormal corpus luteum function has been associated with infertility and incapacity to maintain 
gestation. A subnormal corpus luteum function can display short duration of persistence, or of 
normal duration but low progesterone production (Garverick, Parfet et al. 1988).  In ewes, both 
normal and abnormal CL development are similar until day 4 post-ovulation; nevertheless, at day 
5, abnormal CL diminishes in weight and progesterone secretion and regresses during day 6 
(Hunter, Southee et al. 1988) .  
Abnormal CL may result from a deficiency during the final phases of follicular 
maturation. Braden et al., (Braden, King et al. 1989) demonstrated that abnormal CL originate 
from follicles showing more granulosa cells, fewer LH and FSH receptors, and less 17β-estradiol 
(E2) concentration, in comparison with follicles forming normal corpora lutea (Niswender, 
Juengel et al. 2000).  
 
5.3 Corpus luteum regulation 
It has been known for some time that maintenance of CL depends of luteotropic 
hormones such as LH (Kaltenbach, Graber et al. 1968; Denamur, Martinet et al. 1973), hCG, and 
others such as prolactin, E2, prostaglandin, estrogens and hormones derived from maternal or 
fetal tissues. The importance of these substances depends on the species. LH is considered as the 
most important luteotropin (Keyes and Wiltbank 1988; Berisha and Schams 2005).  One effect of 
LH as luteotropic hormone is through the activation of protein kinases to produce cyclic AMP 
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response element binding (CREB) phosphorylation (Mukherjee, Park-Sarge et al. 1996; Yazawa, 
Mizutani et al. 2003). The interaction of phosphorylated CREB with the coactivator CREB-
binding protein (CBP) stimulates the expression of ovarian genes, but its cAMP dependence is 
lost when luteinization is initiated (Wu and Wiltbank, 2002). Nevertheless, phosphorylation of 
CREB is higher in luteal cells than in granulosa cells, suggesting that other kinases such as 
mitogen-activated protein kinase (MAPK) could be implicated (Gonzalez-Robayna, Alliston et 
al. 1999; Alliston, Gonzalez-Robayna et al. 2000; Hazzalin and Mahadevan 2002).  
 
In some species, such as the rat, rabbit, and pig, estrogens are luteotropic (Stormshak, 
Zelinski-Wooten et al. 1987).  In the rabbit, estradiol has been considered the primary luteotropic 
hormone (Robson 1937) and LH plays a secondary role. In the rat, estradiol and prolactin appear 
to be directly involved in stimulation of progesterone secretion. Similarly prolactin is essential to 
maintain expression of estradiol and LH receptors, and LH stimulates synthesis of estradiol from 
the corpus luteum.  In the pig, the luteotropic role of estrogen is less defined, but the CL growth 
and increase in progesterone secretion are attributed to the estradiol action (Conley and Ford 
1989).  Other luteotropic hormones reported are growth hormone (GH) (Liebermann and Schams 
1994) and IGF-I (Constantino, Keyes et al. 1991; Parmer, Roberts et al. 1991; Sauerwein, 
Miyamoto et al. 1992)  that increased secretion of progesterone from luteal tissue.  GH receptor 
mRNA has been identified in ovine, bovine, and rat luteal tissue (Carlsson, Nilsson et al. 1993; 
Lucy, Collier et al. 1993; Juengel, Nett et al. 1997). Growth hormone could have a direct effect 
on luteal function by increasing secretion of progesterone and oxytocin (Liebermann and Schams 
1994). In addition, GH may influence luteal function indirectly by increasing expression of IGF-I 
(Parmer, Roberts et al. 1991; Obasiolu, Khan-Dawood et al. 1992; Juengel, Nett et al. 1997).  
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Luteal tissues of primates and domestic animals express IGF-I mRNA and protein 
(Talavera and Menon 1991; Obasiolu, Khan-Dawood et al. 1992; Perks, Denning-Kendall et al. 
1995). IGF-I is thought to activate intrinsic tyrosine kinases in luteal cells, to increase secretion 
of progesterone (Chakravorty, Joslyn et al. 1993). Binding of IGF-I stimulates phosphorylation 
of insulin receptor substrate 1 and increases the activity of phosphoinositide 3-kinase. This 
kinase produces the novel phosphoinositide phosphatidylinositol 3-phosphate, acts as a second 
messenger (Chakravorty, Joslyn et al. 1993). This substance appears to influence modification of 
the cytoskeleton and may be involved in prevention of cellular death and apoptosis (Lucy, 
Collier et al. 1993; Davis, May et al. 1996).  
 
The PGs are of particular interest, because of the involvement of PGF2α in regression of 
the CL in many species. Production of PGF2α directly by luteal cells has been reported in cows 
(Milvae and Hansel 1983; Townson and Pate 1994; Townson and Pate 1996) pigs (Guthrie, 
Rexroad et al. 1978; Diaz, Crenshaw et al. 2000), rhesus monkeys (Johnson, Ottobre et al. 1988), 
sheep (Rexroad and Guthrie 1979; Tsai and Wiltbank 1997), and rats (Olofsson, Norjavaara et al. 
1992). Luteal PGF2α production can be regulated by numerous hormones, including 
progesterone, uterine PGF2α, and cytokines such as tumor necrosis factor-α(TNFα), interleukin-
1b (IL1b) and endothelin (ET-1).  On the other hand, PGF2α might play a paracrine role in the 
modulation of luteolytic cascade and can induce strong vasoconstriction, thereby reducing the 
blood supply to the CL during spontaneous luteolysis (Shirasuna, Asaoka et al. 2004). 
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Stimulation of CL also has been proposed by prostaglandins E and I (PGE and PGI) 
(Milvae and Hansel 1980; Milvae and Hansel 1983). These prostaglandins are produced in 
higher amounts in the early luteal phase than the late luteal phase and thus are proposed to play a 
role in luteal development (Milvae and Hansel 1983). In cows, ewes, and humans PGI2 also 
increased secretion of progesterone (Fitz, Hoyer et al. 1984; Alila, Corradino et al. 1988; 
Bennegard, Hahlin et al. 1990; Graves, Pierce et al. 1995).  In humans, treatment of luteal cells 
with PGI2 was shown to increase cAMP accumulation, suggesting that PGI2 may increase 
secretion of progesterone through activation of PKA (Fitz, Hoyer et al. 1984;  Bennegard, Hahlin 
et al. 1990). However the intracellular mechanism by which PGI2 increases secretion of 
progesterone is not clear. 
 
PGE2 also has been shown to increase progesterone production from luteal cells.  These 
prostaglandins presumably have similar actions as PGI, increasing cAMP and PKA with the final 
gene transcription (Marsh 1976). Mamluk et al (Mamluk, Defer et al. 1999), have shown that 
physiological concentrations of Ca2+ ions (up to 5 mM) significantly stimulated cAMP 
production in luteal cells; and that the effects of Ca2+ on cAMP synthesis and adenyl cyclase 
(AC) activity.  These data may delineate the cross-talk between physiological activators of AC in 
the CL (such as LH, PGE2, and PGI2) and other ligands (such as PGF2α and endothelin-1), 
which indirectly modulate AC activity.  
 
Similarly, progesterone seems to be a key factor for adequate CL development, due to the 
fact that progesterone receptor knockout mice are infertile due to failure of ovulation (Mulac-
Jericevic, Mullinax et al. 2000; Drummond 2006). The progesterone receptor inhibitors RU486 
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and ZK98299 blocked LH-stimulated luteinization of granulosa cells isolated from preovulatory 
follicles and RU-486 inhibited progesterone action and reduced 3α hydroxysteroid 
dehydrogenase activity (Dimattina, Albertson et al. 1986; Natraj and Richards 1993). 
 
Cytokines are also potent stimulators of luteal PGF2α production. IL1b and TNFα 
dramatically stimulated PGF2α production by cultured bovine luteal cells (Nothnick and Pate 
1990; Benyo and Pate 1992; Townson and Pate 1994). The acute stimulation of PGF2α 
production has been postulated to occur through activation of cPLA2 (Townson and Pate 1994; 
Townson and Pate 1996). In human luteinized granulosa cells IL1b was also found to increase 
prostanoid synthesis, increase Cox-2 mRNA synthesis, and decrease Cox-2 mRNA degradation 
(Narko, Ritvos et al. 1997). Treatment with interferon-τ has also been found to stimulate luteal 
PGF2α production (Fairchild and Pate 1991). Of particular importance, all of the stimulatory 
effects of these cytokines on PGF2a production could be inhibited by simultaneous treatment 
with progesterone (Nothnick and Pate 1990; Townson and Pate 1996). Although cytokines 
increase PGF2α production, it does not appear that PGF2α production is required for cytokine-
mediated inhibition of progesterone production or induction of cell death (Fairchild and Pate 
1991; Petroff, Petroff et al. 2001). 
As mentioned before, ET-1 is also critical in luteolysis (Milvae 2000). Treatment with 
ET-1 decreases progesterone production in bovine luteal cells in vitro or in vivo, an effect 
blocked by a specific ET receptor antagonist (Girsh, Milvae et al. 1996; Hinckley and Milvae 
2001). Additionally, ET-1 treatment induces PGF2α production by luteal cells (Girsh, Milvae et 
al. 1996; Miceli, Minici et al. 2001). Thus, ET-1, as well as other cytokine peptides, has complex 
but critical relationships with PGF2α and progesterone during luteolysis.  
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5.4 Gene expression in the corpus luteum 
Follicular cell transformation into luteinized cells occurs few hours after LH surge, 
during which there are important genomic changes allowing terminal differentiation also known 
as luteinization. The purposes of these changes are to arrest cell division and preparing cells for 
different hormonal secretions. Endocrine/paracrine factors up-regulate genes to initiate and 
maintain corpus luteum structure and function. These include StAR, PR, ERα, and corticotropin 
releasing hormone binding protein (CRHBP) (Xu, Stouffer et al. 2005).  Similarly, signal 
transduction factors including CCAAT/enhancer binding proteins (C/EBPβ) are important 
regulators of luteinization (Sterneck, Tessarollo et al. 1997). While transcripts implicated in gene 
up-regulation such as LIM domain only 7 (LMO7); cell growth/proliferation factors; as well as 
genes implicated in tissue remodeling and toxicity e.g. glutathione S-transferase (GST). GST is a 
soluble enzyme catalyzing unsaturated carbonyls (Hayes and Strange 2000; Al-Gubory, 
Ceballos-Picot et al. 2005);  GST is believed to exert a critical role in cellular protection against 
oxidative stress and toxic foreign chemicals. They detoxify a variety of electrophilic compounds 
(Hayes and Strange 2000).  In addition to GST action, reduction in toxicity will be favored by 
metallothionein (MT-1) secretion. These substances are a family of metal binding proteins 
believed to participate in a cellular defense detoxifying agents of other reactive metals and free 
radicals (Thornalley and Vasak 1985; Liu, Kershaw et al. 1991; Liu, Liu et al. 1995). It has been 
speculated that MT-1 functions to regulate steroid synthesis and/or with inflammatory processes 
(Miles, Hawksworth et al. 2000; Espey, Ujioka et al. 2003).  
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6. CHOLESTEROL IMPORTATION INTO STEROIDOGENIC TISSUE 
 
Cholesterol is the precursor molecule of steroid hormones, and steroidogenic tissue acquires and 
synthesizes this molecule.  The de novo production of cholesterol by steroidogenic cells is 
achieved by endogenous synthesis from acetate (Carr, MacDonald et al. 1980; Lehoux and 
Lefebvre 1980), with rate limitation by HMG-CoA reductase. Cells import cholesterol from 
circulating lipoprotein (Brown and Goldstein 1979; Gwynne and Strauss 1982; Glass, Pittman et 
al. 1983; Glass, Pittman et al. 1983); and cholesterol can be acquired by hydrolysis of cholesterol 
ester stored in cytoplasmic lipid droplets (Reaven, Tsai et al. 1996). Figure 2, is adapted from 
Azhar and Reaven  (Azhar and Reaven 2002) and presents the sources of cholesterol supply to 
cells. 
 
6.1 LDL cholesterol importation 
Low density lipoprotein importation is an important method of supplying cholesterol to 
cells.  The following concept is based on a series of reviews on the subject (Brown and Goldstein 
1979; Schneider, Beisiegel et al. 1982; Mahley and Innerarity 1983; Brown and Goldstein 1986).  
LDL is a plasma lipoprotein particle of which its lipid component includes cholesterol, 
triglycerides and apolipoproteins. In humans, LDL originates from very-low density lipoprotein 
(vLDL) produced by the liver with the apoprotein B-100.  The vLDL is converted to LDL by the 
action of lipoprotein lipase, an enzyme that hydrolyzes triglycerides in vLDL and releasing free 
fatty acids. 
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Figure 2. Principal sources of cholesterol, and key enzymes involved in cholesterol metabolism 
by steroidogenic tissue for steroid biosynthesis. HDL, high- density  lipoproteins; SR-
BI, scavenger receptor class B type I; LDL, low density lipoproteins; LDLr, low 
density lipoproteins receptors; CE, cholesteryl ester;; CS, Cytoskeleton; EV, 
Endocytic vesicles; Lis, lysosomes. A HMG CoA redustase. B Acyl-Coenzyme A: 
cholesterol acyltransferase (ACAT). C Cholesteryl ester (CE) hydrolase. D putative 
cholesterol transport factors (SAP, steroidogenic activator polypeptide; SCP, sterol 
carrier protein; StAR, steroidogenic acute regulatory protein; PBR, peripheral-type 
benzodiazepine receptor). E P450scc (Azhar and Reaven 2002). 
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The removal of triglycerides from vLDL by lipoprotein lipase leaves a greater proportion 
of cholestrol, decreasing the density of the particle. One means of cellular cholesterol intake is 
by LDL endocytic pathway in which apolipoproteins Apo-B or Apo-E are recognized by the 
LDL receptor (LDLr), via clathin-coated pit-mediated endocytosis, in which, the entire 
lipoprotein is internalized in the pits and originate the coated vesicles going to the lysosomes to 
be degraded, releasing free cholesterol, available to be transported to the mitochondria where it is 
converted to steroids molecule or other cellular metabolites. The autosomal recessive 
hypercholesterolemia protein, a cytosolic polypeptide with a phosphotyrosine-binding domain 
was identified as regulator for clathrin-coat pits and LDLr-mediated endocytosis (Mishra, 
Watkins et al. 2002). Its presumed influence on LDLr activity is by binding to the NPYX 
endocytic motif of the cytoplasmic region of the receptors (Garcia, Wilund et al. 2001). 
Transcriptional regulation of the LDLr pathway helps ensure cellular cholesterol homeostasis via 
membrane-bound transcription factors known as sterol regulatory element (SRE)-binding 
proteins (SREBPs; Brown and Goldstein 1999).  Liver and steroidogeneic tissues express this 
transcription factor, where about 70% of the LDLr activity is concentrated. However, whether 
LDL serves as a source of cholesterol for luteal steroidogenesis, appears to be species-dependent 
(Brannian and Stouffer 1993). 
 
6.2 HDL cholesterol importation 
The HDL receptor, SR-BI, mediates the selective uptake of cholesterol and is highly 
expressed in cholesterol dependent cells and in steroidogenic cells where SR-BI can influence 
plasma HDL cholesterol levels, storage, and utilization of cholesterol in steroid hormone-
producing cells (Azhar, Nomoto et al. 1998; Li, Peegel et al. 1998). SR-BI brings cholesterol 
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ester into the cells, by a mechanism that does not involve internalization of ApoAI or ApoAII, 
the two major protein components of HDL (Sparrow and Pittman 1990; Johnson, Mahlberg et al. 
1991; Connelly, Kellner-Weibel et al. 2003). In a process called “selective lipid uptake” 
observations by ultrasensitive fluorescence microscopy found that HDL particles were 
endocytosed as clusters and actively transported to the perinuclear region of the cell and the 
uptake of  HDL by an acidic compartment in the Golgi apparatus with a final re-secretion of the 
HDL particles (Rhode, Breuer et al. 2004). These results were supported by a study using 
electron microscopy and 125I-labeled HDL (Pagler, Rhodes et al. 2006).  
 
6.3 Generalities about SR-BI 
Scavenger receptor class B, type I, SR-BI, is a 509-residue, 82-kDa integral membrane 
cell surface glycoprotein of the CD36 superfamily that was the first HDL receptor to be 
characterized in detail (Calvo and Vega 1993; Acton, Scherer et al. 1994). Protein expression 
was confirmed by Western blot analyses with human SR-BI polypeptide antibodies to show a 
major 83-kDa band. Confocal immunofluorescence microscopy demonstrated that hSR-BI 
immunoreactive mass was detectable in a heterogeneous, punctate staining pattern (Hirano, 
Yamashita et al. 1999).  
 
The chromosomal locations of the rat SR-BI gene and its human homolog, the CD36- and 
LIMPII analogous-1 (CLA-1) gene, were determined by in situ hybridization, the rat gene was 
mapped between bands q15 and q16 on rat chromosome 12 (RNO12q15–16), and the human 
locus, determined by somatic cell hybrids, has been assigned to chromosome 12 between bands 
12q24.31 and q24.32 (Johnson, Svensson et al. 1998).  The SR-BI gene contains 13 exons, most 
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of which are small (less than 204 bp) (Cao, Garcia et al. 1997). In the porcine endometrium, SR-
BI gene was mapped to 46.3 cM on chromosome 14, and these results show that SR-BI 
chromosome localization differs among species (Kim, Vallet et al. 2004).  There is close identity 
to hamster, mouse, rat and human sequences (Rajapaksha, McBride et al. 1997), thus SR-BI 
presents a short cytoplasmic N-terminus of 9 amino acids followed by a first transmembrane 
domain of 22 amino acids, the extracellular domain of 408 amino acids, the second 
transmembrane domain of 22 amino acids, and the cytoplasmic C-terminus of 47 amino acids, 
see fig. 3 (Han and Lee 2002).  There is a leucine zipper motif and a peroxisomal targeting 
sequence (Johnson, Svensson et al. 1998). 
 
 
Figure 3. Protein domains and configuration of SR-BI inserted in the plasma membrane. 
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6.4 SR-BI intracellular location 
Immunolocalization at the ultrastructural level showed that SR-BI was associated with 
microvilli and microvillar channels of the luteal cell surface, suggesting that microvilli and 
microvillar channels represent a cell surface compartment for the selective uptake of lipoprotein 
cholesterol into steroidogenic cells. (Reaven, Nomoto et al. 1998).  Another structural protein, 
caveolin, is involved in SR-BI transfer of cholesterol (Azhar, Nomoto et al. 1998; Azhar, Luo et 
al. 1999), althougth caveolin displays an inverse relationship to selective cholesteryl ester 
uptake,  being most prominent in basal cells and least prominent in luteinized, HDL-incubated 
cells (Azhar, Nomoto et al. 1998). There were no changes in caveolin expression under 
activation of selective lipid uptake, suggesting that caveolin may not be functionally involved in 
this process (Reaven, Nomoto et al. 1998). 
 
6.5 Tissue and cell type-specific expression of SR-BI 
Tissue profiles demonstrate highest expression of SR-BI in the ovary, adrenal, liver, 
spleen and placenta (Acton, Rigotti et al. 1996; Landschulz, Pathak et al. 1996; Rigotti, Edelman 
et al. 1996; Cao, Garcia et al. 1997).  SR-BI was localized by immunofluorescence to the surface 
of steroidogenic cells in the zona fasciculata and zona reticularis of the adrenal gland and in the 
CL (Landschulz, Pathak et al. 1996). In the ovary, in situ hybridization revealed expression 
nearly exclusively in the theca and interstitial cell (Svensson, Johnson et al. 1999; Li, Peegel et 
al. 2001) compartments of developing follicles.  In rat and bovine (Argov, Moallem et al. 2004) 
ovaries, transcript abundance appears to increase as follicular development ensues (Rajapaksha, 
McBride et al. 1997). HDL-receptor mRNA levels were low in isolated bovine granulosa cells, 
but increased by 7-fold during corpus luteum development in vivo, and by 5-fold during 
granulosa cell luteinization in culture, showing that luteinization of bovine granulosa cells is 
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associated with an increase in HDL-receptor RNA levels along with changes in steroidogenic 
enzyme activity (Rajapaksha, McBride et al. 1997). A significant increase in SR-BI gene 
expression was detected in the late phase of corpus luteum formation, and transcripts were 
abundant in corpus luteum and in thecal cells at all stages of follicular development (Johnson, 
Svensson et al. 1998). 
 
Unlike in rodents, SR-BI is highly expressed in the human placenta. Apparently, at this 
level, it is important for lipoprotein importation as a cholesterol source for membrane synthesis, 
required for tissue growth in the developing embryo and for steroid hormone production in the 
extraembryonic tissues (Hatzopoulos, Rigotti et al. 1998). In pregnant animals, the mammary 
gland also expresses high levels of the SR-BI protein (Landschulz, Pathak et al. 1996). 
 
6.6 SR-BI: Hormonal regulation 
The evidence that SR-BI is the selective uptake receptor for HDL-cholesterol esters in 
steroidogenic tissues came from studies showing that SR-BI is upregulated by ACTH in murine 
adrenal glands and in Y1-BS1 cells where synthesis of SR-BI was induced (Reaven, Nomoto et 
al. 2006). In the adrenal cortex of mice injected with ACTH, alone or in combination with 17-
ethinyl-estradiol SR-BI expression increased (Rigotti, Edelman et al. 1996; Azhar, Nomoto et al. 
2002). Steroidogenic factor-1 (SF-1) seems to be necessary for full SR-BI encoding of gene 
expression in human adrenal cells (Cao, Garcia et al. 1997). In addition, angiotensin II promotes 
SR-BI-mediated selective uptake of HDL-CE in the bovine adrenal glomerulosa, and in NCI-
H295R human adrenocortical cells; apparently, HDL via SR-BI is the major cholesterol source 
for aldosterone biosynthesis (Pilon, Martin et al. 2003).  
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 In the rat ovary, SR-BI expression is upregulated by gonadotropin stimuli, as SR-BI 
transcript abundance was increased twofold in the immature rat ovary following eCG 
administration and in response to stimulation by hCG, resulting from 2.5 to sevenfold increase in 
the transcript at 3 to 6 h postinjection, respectively (Azhar, Nomoto et al. 1998; McLean and 
Sandhoff 1998; Rigotti, Miettinen et al. 2003).  This increase corresponded to a 58% increase in 
serum progesterone.  The combination of luteinizing hormone (LH) and insulin has a stimulatory 
effect on the expression of SR-BI in theca-interstitial cells and induces theca cell steroid 
synthesis (Li, Peegel et al. 2001; Towns, Azhar et al. 2005).  Antibody neutralization of SR-BI in 
rat theca cell cultures reduced gonadotropin-stimulated steroidogenesis by 90% (Wu, Sucheta et 
al. 2003), attesting to the importance of SR-BI in cholesterol supply in this follicular 
compartment.  
 
6.7 SR-BI molecular regulation 
As previously mentioned, cholesterol homeostasis in mammalian cells is regulated by a 
unique family of transcription factors known as sterol regulatory element binding proteins 
(SREBPs). Sterol regulatory elements (SRE) have been identified in the SR-BI gene (Sudhof, 
Russell et al. 1987). SR-BI presents two SRE, one distal and one proximal (Lopez and McLean 
1999), the SRE1 contains the information necessary for mediation of sterol regulation. 
 
Cao (Cao, Garcia et al. 1997) described the structure and subchromosomal location of 
human SR-BI, providing evidence for its regulation through the steroidogenic factor 1 (SF-1). 
SF-1, an orphan member of the nuclear hormone receptor gene family, plays a key role in 
steroidogenesis and is expressed at higher levels in specialized steroidogenic tissues. SF-1 binds 
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to the SR-BI promoter in a sequence-specific manner, and the efficient transcription from this 
promoter in the adrenocortical Y1 cells is dependent on an intact SF-1 site.  SR-BI contains one 
SF-I-binding motif (Lopez, Sanchez et al. 2002). 
 
It has been well established that negative factors also play a critical role in gene 
regulation. One important SR-BI negative controlling factor seems to be the dosage-sensitive sex 
adrenal hypoplasia congenital critical region on the X chromosome gene-1 (DAX-1) wich is 
colocalized with SF-1 in steroidogenic tissues (Ikeda, Swain et al. 1996) suggesting that DAX-1 
and SF-1 may function assembled or sequentially (Ito, Yu et al. 1997; Crawford, Dorn et al. 
1998). DAX-1 can strongly repress steroidogenesis and antagonize SF-1-mediated stimulation of 
genes such as SR-BI, leading to a decrease in its mRNA (McLean and Sandhoff 1998). In 2003, 
Kocher et al. (2003) reported a novel mechanism for the physiological and pathophysiological 
regulation of hepatic SR-BI by PDZK1 (PDZ domain-containing-1 protein) in a tissue-specific 
and post-transcriptional fashion. SR-BI protein expression in PDZK1 knock-out (KO) mice was 
reduced by 95% in the liver, 50% in the proximal intestine, and not affected in steroidogenic 
organs (adrenal, ovary, and testis). The PDZ domain-containing adaptor protein PDZK1 has been 
shown to bind to and control the activity of SR-BI. Mice deficient in PDZK1 have elevated 
plasma cholesterol levels due to the virtually complete hepatic ablation of SR-BI (Kocher, 
Yesilaltay et al. 2003; Lan and Silver 2005; Yesilaltay, Kocher et al. 2005). 
 
Point-mutation analysis demonstrated that PDZK1 is phosphorylated at Ser-509, a 
process triggered by PKA in vitro (Nakamura, Shibata et al. 2005)). PDZK1 phosphorylation and  
hepatic SR-BI increase, results in a decrease in plasma HDL levels, indicating that PDZK1 
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phosphorylation has an important role in the regulation of hepatic SR-BI expression and, 
influences plasma HDL levels and that the C-terminal region of PDZK1 is crucial for up-
regulating SR-BI protein expression. (Nakamura, Shibata et al. 2005). 
 
6.8 Other regulators of SR-BI 
Cellular levels of vitamin E (vitE) exert control on SR-BI expression. Witt et al. (Witt, 
Kolleck et al. 2000) observed that diminishing the amount of vitE in rat diets, resulted in increase 
of expression of SR-BI protein, increased HDL-binding proteins (HB2) and a glycosyl 
phosphatidylinositol-anchored membrane dipeptidase (MDP), with a possible role in the 
selective lipid uptake process, mediated by SR-BI. This effect has been also observed in human 
SR-BI, increases in vitE were accompanied by reduced protein kinase C (PKC) and SR-BI 
levels, showing an vitE inhibitory effect on these molecules (Witt, Kolleck et al. 2000). 
 
Taking into account that lecithin-cholesterol acyltransferase (LCAT) is an important HDL 
component and with the purpose of observing whether LCAT and Apo-I determine SR-BI 
concentration in adrenal, LCAT and Apo-A knockout mice were developed, which demonstrated 
92% reduction in plasmatic lipoproteins as well as 96% in the CE content (Ng, Francone et al. 
1997). These results were associated with a 2-fold up-regulation of adrenal SR-BI mRNA, 
supporting the view that adrenal SR-BI expression is also regulated by the adrenal cholesterol 
(Ng, Francone et al. 1997).  
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6.9 SR-BI deficiency 
Below, SR-BI expression in the liver as well as in steroidogenic cells, and its regulation 
by the action of several trophic hormones was addressed.  Studies on genetically manipulated 
mice strains have established SR-BI’s key role during lipoprotein metabolism regulation and 
cholesterol transportation into steroidogenic tissues and into the liver for biliary secretion 
(Rigotti, Miettinen et al. 2003).  Similarly, SR-BI has been defined as lipoprotein receptor 
responsible for selective CE uptake from HDL and LDL, and in free cholesterol efflux to 
lipoprotein acceptors (reverse cholesterol transport). These activities depend on lipoprotein 
binding to its extracellular domain and the subsequent lipid exchange at the plasma membrane 
(Mardones, Strobel et al. 2002; Out, Kruijt et al. 2004; Lopez and McLean 2006).   
 
HDL may have a particularly important role in mammalian female fertility, because in 
many species, including humans, HDL is the main class of lipoprotein found in ovarian follicular 
fluid (Perret, Parinaud et al. 1985; Volpe, Coukos et al. 1991). Mice with targeted homozygous 
null mutations in the SR-BI gene exhibit approximately 2-fold elevated plasma cholesterol 
carried in both normal size and abnormally large HDL particles (Rigotti, Trigatti et al. 1997; 
Trigatti, Rayburn et al. 1999). The ratio of unesterified cholesterol to total cholesterol in plasma 
is abnormally high in SR-BI-/- mice (Braun, Zhang et al. 2003). SR-BI-/- females are infertile 
(Trigatti, Rayburn et al. 1999). SR-BI-/- females ovulate normal numbers of oocytes that are 
dead or defective and thus cannot be fertilized. Although these animals appear to exhibit a 
normal estrous cycle (Trigatti, Rayburn et al. 1999), when ovaries from SRBI-/-  mice are 
transplanted into otherwise SR-BI-positive recipients or genetic/pharmacological manipulation 
of lipoprotein, fertility is partially or fully restored (Miettinen, Rayburn et al. 2001). Inducing 
hepatic SR-BI   expression in SR-BI-/- animals by adenovirus transduction or stable transgenesis 
 44
substantially reduced levels of abnormally large HDL, normalized the unesterified:total 
cholesterol ratio and restored female fertility (Yesilaltay et al. 2006). 
 
 In addition, analysis of SR-BI -/- mice has shown that SR-BI activity is important during 
alpha-tocopherol and nitric oxide metabolism, and normal red blood cell maturation. The role of 
SR-BI/Apo complex has been demonstrated through the knockout mice model for several 
physiological and pathological conditions (Li, Guo et al. 2005). SR-BI/ApoE double knockout 
mice developed acute atherosclerosis 4 weeks after birth.  Similarly, double SR-BI/ApoA 
knockout mice developed premature cardiac failure. The up-or-down regulation of other genes in 
the absence of SR-BI has been documented and the genes affected include those involved in the 
oxidative process, suggesting that SR-BI is not only important for cholesterol transport to the 
cell, but also for the regulation of apoptosis (Li, Guo et al. 2006). 
 
6. 10 Alternate splicing of SR-BI and cholesterol importation 
 As noted above, the mouse SR-BI was the first high-density lipoprotein receptor to be 
identified (Glass, Pittman et al. 1983).  It is highly expressed in tissues with an elevated 
cholesterol demand where it functions to bind mature HDL particles and selectively remove 
cholesteryl esters (Murakami, Horiuchi et al. 1987), and to contribute to cellular cholesterol 
homoeostasis (Graf, Matveev et al. 1999). Alternative splicing of the SR-B gene transcript 
generates two isoforms (types I and II) with identical extracellular regions, but distinct C-
terminal cytoplasmic tails (Azhar and Reaven 2002). SR-BII also termed as SR-BI.2 in mice; and 
CLA-2 in humans, is a high density lipoprotein receptor with an identical extracellular domain 
that contains a further 40 amino acid residues (Calvo and Vega 1993; Cao, Garcia et al. 1997; 
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Webb, de Villiers et al. 1997). It has been described in several tissues, including certain cell 
types in which SR-BI expression is observed (Webb, de Villiers et al. 1997; Reaven, Cortez et al. 
2004). Significant proportions of SR-BII mRNA are expressed in the mouse and the receptor 
binds HDL with high affinity, and mediates both selective lipid uptake through endocytosis via 
clathrin-dependent pathway and cellular cholesterol efflux , although less efficiently than mouse 
SR-BI (Eckhardt, Cai et al. 2004). In contrast to SR-BI, SR-BII does not mobilize intracellular 
chlolesteryl (Webb, de Villiers et al. 1997). 
 
As with SR-BI, SRBII is localized in caveolae (Acton, Rigotti et al. 1996) cholesterol 
rich plasma membrane microdomains that are implicated in cellular cholesterol homoeostasis 
and in cell signaling (Krieger 1999; Williams, Connelly et al. 1999).  In steroidogenic tissues the 
cell regions termed as the microvillar compartment (Reaven, Boyles et al. 1988; Reaven, Spicher 
et al. 1989), and the specialized space created between them are apparently implicated in the 
selective uptake of lipoprotein CEs into cells regulated by SR-BI and its isoform SR-BII 
(Reaven, Shi et al. 1990). Electron microscopic and immunocytochemical techniques reveal 
heavy labeling for SR-BI specifically in these regions (Reaven, Nomoto et al. 1998; Azhar, 
Nomoto et al. 2002). In Chinese hamster ovary cells the distribution of SR-BII differs from SR-
BI, as SR-BI is mainly (approximately 70%) localized on the surface of transfected cells, while 
the majority of SR-BII (approximately 80-90%) is expressed intracellularly, the distinct C 
terminus of SR-BII is responsible for its intracellular expression  (Eckhardt, Cai et al. 2004). 
During the process to elucidate the cell distribution of SR-BII, a novel isoform expressed in 
human macrophages and in human atherosclerotic plaques was described (Svensson, Englund et 
al. 2005). 
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The tissue location of SR-BI is considered similar to the SR-BII, but there is currently 
little information on the SR-BII in the ovary (Akpovi, Yoon et al. 2006). 
 
7. STEROIDOGENESIS 
 
In mammals there are several tissues where elaboration of steroids takes place: ovary 
(follicles and corpus luteum), testis, adrenal glands, placenta, nervous system (Baulieu 1998; 
Mellon and Griffin 2002) and in the heart (Kayes-Wandover and White 2000; White 2003). Each 
tissue synthesizes and secretes different steroid products, however all the steroids have 
cholesterol as precursor molecule. Herein, only steroidogenesis in the follicles and corpus luteum 
is mentioned because it fulfills important functions in reproduction.  
 
7.1 Follicular steroidogenesis 
Follicles provide a suitable micro-environment for oocyte development. This atmosphere 
is promoted through hormonal and non-hormonal secretions. The main products secreted within 
the follicles are estrone, estradiol-17β, androstenedione, testosterone, progesterone and 
pregnenolone and these play a very important role in mammalian reproductive system  
(Lunenfeld, Kraiem et al. 1975; Kagawa, Kuwayama et al. 2005). 
 
The estrogen of major importance in follicular steroid synthesis is E2, synthesized in 
granulosa cells.  Its physiologic actions include the regulation of receptivity during the estrus 
phase, regulation of ovarian cycle, neuroprotection to prevent neuron death (Bains, Cousins et al. 
2007), regulation during synaptic communication (Hajszan, Maclusky et al. 2007), protection 
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against hypertension (Ashraf and Vongpatanasin 2006). Indeed, estrogens regulate multiple 
reproductive and non-reproductive mechanisms.  
 
The ovarian cells processed cholesterol to steroids (Sasano, Okamoto et al. 1989), the 
theca cells synthesized androgens, which represents the granulosa substrate for estrogen 
production. However, Tepenainen et al found that human granulosa displays aromatase activity 
in response to hCG, FSH and estrogens (Tapanainen, McCamant et al. 1991). 
 
Androgens produced by the theca are aromatized to estradiol in granulosa cells under the 
influence of FSH, rendering estradiol. Mature rat granulosa cells acquire the capacity to respond 
to LH by increasing its receptors, an action controlled through FSH (Mondschein and Schomberg 
1981). Also, control of estradiol production in granulosa cells is complemented in a complex 
interaction of growth factors, specially members of TGF-β superfamily (Knight and Glister 
2006).    
 
Synergy of FSH with insulin-like growth factor (IGF) induces estradiol production 
(Hirakawa, Minegishi et al. 1999; Minegishi, Hirakawa et al. 2000; Minegishi, Hirakawa et al. 
2004).  Estrogen production by granulosa cells is also regulated by inhibin and activin which 
regulate FSH secretion and by autocrine action, increasing LH receptors in granulosa cells 
(Glister, Tannetta et al. 2001; Knight and Glister 2001; Welt 2002). 
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7.2 Key enzymes in steroidogenesis 
Considering the importance of cholesterol during steroidogenesis, equilibrium between 
CE and free cholesterol depends of a number of enzymes, including rate- limiting enzymes in 
cholesterol biosynthesis, cholesterol acyl transferase (ACAT), the cholesterol esterases and 
HMG-CoA reductase (Lennernäs 1997). Cellular structures, such as mitochondria and smooth 
endoplasmic reticulum, are the sites where the enzymatic complex necessary for steroid 
synthesis is located. Steroidogenic enzymes may be classified into two major classes: the 
cytochrome P450 heme-containing proteins and the hydroxysteroid dehydrogenases (Payne and 
Hales 2004; see table 1).  
 
The enzymatic complexes act at different levels in steroid biosynthesis, after cholesterol 
entrance into the cell the first rate-limiting enzyme is P40scc (also known as cyp11A1) that acts 
in cleavage of the side-chain of cholesterol, this enzyme is located on the matrix side of the inner 
mitochondrial membrane (Payne and Hales 2004). The first enzymatic step culminates with 
elaboration of pregnenolone (Burstein and Gut 1976) a common molecule in steroidogenesis 
(Miller 1988; Miller 1995). Conversion to progesterone is controlled by Δ5-3β-hydroxysteroid 
dehydrogenase (3ßHSD). Androgen synthesis is a rate-limiting step in the follicular estrogen 
production and is controlled by the 17α-hydroxylase and the C-17, 20-lyase enzymes.   The 
reaction can utilize either pregnenolone by the 5-ene-3ß-hydroxy  pathway  (Δ5 pathway); or 
progesterone through the action of 4-ene-3-oxo or Δ4 pathway, depending on the species. For 
example, humans and cattle favor the Δ4  pathway while rodents use the Δ5 pathway. The final 
step in steroidogenesis is the aromatization of androgens to estradiol in granulosa cells by the 
P450arom. (Graham-Lorence, Khalil et al. 1991; Simpson, Mahendroo et al. 1994). 
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          Gene 
Human          Mouse 
Protein         Synonyms Tissues expression
CYP11A1   Cyp11a1 CYP11A P450scc, cholesterol side-
chain cleavage, cholesterol 
desmolase,cytochrome P450 
cholesterol side-chain 
cleavage 
Ovary 
 
CYP17B1   Cyp17  CYP17 P450c17, 17α-
hydroxylase/17,20 lyase, 
P45017α-hydroxylase/c17-20 
lyase 
Ovary (theca 
cells) 
CYP19       Cyp19 CYP19 Aromatase, P450arom, 
cytochrome P450arom, 
estrogen syntase 
Ovary (granulosa 
cells) 
HSD17B1  Hsd17b2 17HSD1 17β-HSD1, estradiol-17β 
dehydrogenase, estrogen 17-
oxidoreductase  
Ovary 
HSD17B7  Hsd17b7 17HSD7 17β-HSD7, 17βHSD/17-keto 
steroid reductase 7 
Corpus luteum 
HSD3B2    Hsd3b1 3β HSDII 
human 
3β HSDI  
mouse 
3-HSD type I (type 
VI), 3-HSD/5- 4 isomerase, 3- 
hydroxy-5-steroid 
dehydrogenase, 3-hydroxy-5-
ene steroid dehydrogenase 
Ovary 
 
Table 1. Hydroxysteroid deshydrogenase and  P450enzymes involved in active ovarian steroid 
hormone biosynthesis [adapted from Payne and Hales 2004] 
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7.3 Luteal steroidogenesis 
The main steroid synthesized by luteal cells is progesterone.  The corpus luteum is 
composed of a mixture of cells and interaction between these cell types is essential to maintain 
the luteal steroidogenic function. Progesterone is not the only steroid produced in corpus luteum 
since androstenedione and E2  have been found in rodents, pigs and primates (Oon and Johnson 
2000; Knight and Claire 2006).  As in follicular cells mitochondria plays an important role and 
pregnenolone production takes place by the initial action of P450scc and other enzymes that 
collaborate in the process increasing progesterone levels. The 3βHSD enzyme increases 
dramatically in CL (Oonk, Krasnow et al. 1989; Kaynard, Periman et al. 1992). As in follicular 
steroidogenesis, P450scc catalyzes conversion of cholesterol to pregnenolone.  
 
The involvement of luteal steroidogenesis of stimulatory and inhibitory enzymes are 
listed in a Table 1. 20α-hydroxysteroid dehydrogenase (20αHSD) catabolizes progesterone into 
inactive components (Wiest, Kidwell et al. 1968; Stocco, Zhong et al. 2000); 26-cholesterol 
hydroxylase catalyzes the conversion of cholesterol to the inactive form 26-hydroxycholesterol 
(Yoshida, Kubota et al. 1999); and 5α-reductase, transforms testosterone to dihydrotestosterone 
(DHT).  These enzymes reduce the activity of the steroidogenic machinery and thus reduce the 
cellular capacity for steroidogenesis. 
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8. HYPOTHESIS AND OBJECTIVES  
 
8.1 Experimental goals 
There is little information about cholesterol importation during the luteinization. We 
hypothesize that SR-BI activity is a significant cholesterol source to support luteinization and 
when SR-BI activity is compromised alternative cholesterol sources will be developed to 
maintain corpus luteal steroidogenesis.  The goal of this work was therefore to determine the 
importance of the cholesterol importation mechanisms during the luteinization process, by the 
analysis of LDLr, SR-BI as well as HMG-CoA reductase expression in the porcine and mice 
ovaries, and by means of experimental paradigms to invoke luteinization in vivo and in vitro.   
 
 
 
 
 
 
 
  
 
 52
 
CHAPTER ONE 
 
Title: LIPOPROTEIN RECEPTOR EXPRESSION DURING LUTEINIZATION OF 
THE OVARIAN FOLLICLE 
 
 
Short title:  SR-BI and LDL receptor in luteal formation 
 
 
Authors: Leonor Miranda-Jiménez1,2 and Bruce D. Murphy1 
Affiliations: 1Centre de recherche en reproduction animale, Faculté de médecine vétérinaire, 
Université de Montréal, C.P. 5000, St-Hyacinthe, Québec Canada J2S 7C6 
2Colegio de Postgraduados-CONACYT, México.  
 
 
Corresponding author: Bruce D. Murphy, Centre de recherche en reproduction animale, Faculté 
de médecine vétérinaire, Université de Montréal, C.P. 5000, St-Hyacinthe Québec, Canada 
J2S7C6, telephone 450 773 8521 ext. 18382, facsimile 450 778 8103, email  
Key words: Ovary, lipoprotein receptors, gene expression, ovulation, luteinization  
Published as: Am J Physiol Endocrinol Metab 293: E1053-E1061, 2007.   
 
 
 53
ABSTRACT  
Ovarian follicles luteinize following ovulation, requiring structural and molecular 
remodeling along with exponential increases in steroidogenesis.  Cholesterol substrates for luteal 
steroidogenesis are imported via scavenger receptor-BI (SR-BI) and the low density lipoprotein 
receptor from circulating high and low density lipoproteins (HDL and LDL) respectively.  SR-BI 
mRNA is expressed in pig ovaries at all stages of folliculogenesis and of the corpus luteum (CL).  
An 82 kDa form of SR-BI predominates throughout, weakly present in granulosa cells, and 
robustly expressed in the CL, along with the less abundant 57 kDa form.  Digestion of N-linked 
carbohydrates substantially reduced the SR-BI mass in luteal cells, indicating differences 
between forms is attributable to glycosylation.  Immunohistochemistry revealed SR-BI to be 
concentrated in the cytoplasm of follicular granulosa cells while found mostly at the periphery of 
luteal cells.  To examine receptor dynamics during gonadotropin-induced luteinization, pigs were 
treated with an ovulatory stimulus, and ovaries were collected at intervals to ovulation.  SR-BI in 
granulosa cell cytoplasm increased through the peri-ovulatory period, with migration to the cell 
periphery as the CL matured.  In vitro culture of follicles with hCG induced time-dependent 
upregulation of 82 kDa SR-BI in granulosa cells.  SR-BI and LDL receptor were reciprocally 
expressed, with the latter highest in follicular granulosa cells, declining precipitously with CL 
formation.  We conclude that luteinization causes upregulation of SR-BI expression, its post-
translational maturation by glycosylation and insertion into luteal cell membranes.  Expression of 
the LDL receptor is extinguished during luteinization, indicating dynamic regulation of 
cholesterol importation to maintain elevated steroid output by the corpus luteum. 
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INTRODUCTION 
The formation of the corpus luteum (CL) following rupture and collapse of the ovulating 
follicle requires widespread cell and tissue remodeling, driven by extensive changes in gene 
expression (17).  A significant aspect of luteal remodeling is the shift from estrogen as the 
principal steroid product to progesterone, a change accompanied by a large-scale increase in total 
steroid synthesis.  At the peak of their output during the late follicular phase, estrogens are 
synthesized only in µg/day, while the human CL secretes as much as 40 mg/day of progesterone 
during the luteal phase (13).  To achieve this amplification in steroidogenesis, a major increase in 
the amount of the steroid parent molecule, cholesterol, is required.  The quantitatively most 
important supply of cholesterol for luteal steroid synthesis arrives by importation from 
extracellular sources, in the form of high and low density lipoprotein (HDL and LDL) borne 
cholesterol (3, 20).   
Importation of lipoprotein-cholesterol from LDL and HDL is mediated by specific 
membrane receptors.  The endocytic LDL receptor system and attendant cholesterol importation 
has been abundantly characterized in a number of tissues, including the ovary (3, 20).  In recent 
years, it has been shown that HDL importation depends upon a cell surface glycoprotein known 
as scavenger receptor B1 (SR-BI), a glycoprotein comprised of two transmembrane and two 
cytoplasmic domains and a large, N-glycosylated extracellular loop (24).  The SR-BI gene codes 
for a protein with a predicted mass of 57 kDa, while immunoblot and immunoprecipitation 
experiments reveal an apparent mass of 82 kDa (1), suggesting extensive glycosylation.  SR-BI 
is inserted in the plasma membrane as a functional dimer where it serves as high capacity bulk 
cholesterol delivery system (23).  
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Tissue profiles demonstrate highest expression of SR-BI in the ovary and adrenal of the 
rat (10), and in situ hybridization revealed that expression is restricted to the theca compartment 
of developing follicles (24).  In the rat (11) and bovine (2) ovaries, transcript abundance appears 
to increase as follicular development ensues.  In the rat ovary, SR-BI expression is up-regulated 
by folliculogenetic stimuli, in particular, the combination of luteinizing hormone (LH) and 
insulin, that induces theca cell steroid synthesis (12).  Antibody neutralization of SR-BI in rat 
theca cell cultures reduces gonadotropin-stimulated steroidogenesis by 90 % (28), attesting to the 
dominance of SR-BI in cholesterol supply in this follicular compartment.  In the rat, SR-BI 
expression becomes established with the remodeling of the ovary during luteinization, as first 
shown in vitro by Azhar et al. (4), and evidenced by a large scale increase in expression of the 
SR-BI message in the developing corpus luteum (11).  These changes are evident at 12 h after 
the ovulatory stimulus, around the time of ovulation.  In vitro evidence supports a role for 
gonadotropin regulation of SR-BI, as treatment of rat luteal cells with the luteinizing hormone 
analog, human chorionic gonadotropin (hCG) provokes both the expression and dimerization of 
the mature (82 kDa) form of SR-BI (23).  As little is known about kinetics of the changes in gene 
expression that accompanies the formation of the corpus luteum, we undertook exploration of the 
mechanisms of importation of cholesterol during the luteinization process by examination 
expression of the LDL receptor and SR-BI in the porcine ovary and by means of experimental 
paradigms to invoke luteinization in vivo and in vitro.  
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MATERIALS AND METHODS  
Animals, tissues and treatments 
All animal experiments were approved by the University of Montreal Animal Care 
Committee and performed according to the Canadian Council of Animal Care regulations.  To 
determine the temporal expression and cellular localization of SR-BI protein throughout the 
ovulatory process, 15 gilts were treated with 500 iu equine chorionic gonadotropin followed by 
100 IU human chorionic gonadotropin (hCG) (Intervet Canada Ltd. Whitby, ON) to induce 
ovulation.  Ovaries were recovered at 0 h, 24 h, 30 h, and 38 h after hCG administration.  In 
other trials, pig ovaries were collected at the slaughterhouse.  Follicular fluid rich in granulosa 
cells was aspirated from small (< 3mm diameter), medium (4-7 mm) and large (>8 mm) follicles 
and washed three times prior to RNA and protein analysis.  CL classified according to their 
developmental morphology (19) as postovulatory (CL-I), developing (CL-II), mid-luteal (CL-III) 
and regressing (CL-IV).  To investigate SR-BI protein expression in situ, whole follicles between 
3.5 mm and 5 mm in diameter were dissected from ovaries acquired at the slaughterhouse and 
cultured in Opti-MEM (Invitrogen, Carlsbad CA) containing 1 % insulin and 10 % fetal bovine 
serum (FBS, Invitrogen).  At 12 h following initiation of incubation, hCG, (100 iu or 500 iu) was 
added to the culture media and follicle cultures were terminated after a further 12 h or 30 h of 
incubation.  For follicle culture, granulosa cells were aspirated from three independent follicles 
and rinsed with culture medium to eliminate follicular fluid.  We employed a further paradigm of 
in vitro luteinization of granulosa cells as previously described (22).   Briefly granulosa cells 
from of 3-5 mm diameter follicles were aspirated from slaughterhouse ovaries and seeded at the 
rate of 7.5 million cells per milliliter of Opti-MEM containing 1% insulin and 10% FBS.  Cells 
were treated with medium alone or medium plus 5 µg/ml actinomyocin-D (Sigma).  After 24 h 
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medium was changed and fresh medium or medium + 100 ng/ml luteinizing hormone (LH NIH 
USDA), was added.  Cultures were terminated 24 or 48 h later.  In a second trial, freshly isolated 
granulosa cells were incubated in medium containing 10 % FBS or 10 % fetal bovine 
lipoprotein-depleted serum (FBLDS; Gibco BRL) for 48 h.  In both the whole follicle and 
isolated granulosa cell culture trials, results were based on three independent experiments from 
ovaries acquired on different days.  
Pig SR-BI Cloning, sequencing, and RT-PCR 
Total RNA extracted from a midcycle porcine CL, quantified by spectrophotometry at 
260 nm, and 1 µg sample was used for reverse transcription (RT) with the Omniscript RT kit 
(Qiagen, Mississauga, ON) according to the manufacturer’s instructions.  SR-BI primers were 
designed based on a homologous sequence in GenBank  (accession AF467889) as follows:  TGA 
CTC CCG AAT CCT CTC TG (forward) and CTG CTC CTT GCT CTG GGCT (reverse).  The 
consequent 550 bp PCR product was resolved on 1 % agarose gel, excised and purified using a 
gel extraction kit (Quiagen).  The cDNA was ligated into a pGEM-T Easy Vector System I 
(Promega Corp., Nepean, ON) according to the manufacturer’s instructions and transformed into 
competent Escherichia coli strain XL-1 blue.  Plasmids were isolated with a QIAprep Spin 
Miniprep kit (Qiagen) and sequenced (Applied Biosystems, Foster City, CA).  Three 
independent samples were sequenced to verify authenticity.  Cell pellet samples and 
approximately 5 mm3 of tissue from each CL were homogenized in buffer containing guanidine 
isothiocyanate (GITC 4.23M) and 0.12 M ß-mercaptoethanol (both from Sigma, St. Louis MO).  
RNA was purified using an RNeasy Protect Mini kit (Qiagen) as recommended by the 
manufacturer.  Pig specific primers (GTC CAT GCC ATC ACT GCC ACT TG, forward and 
CCT GCT TCA CCA CCT TCT TG, reverse) for glyceraldehyde 3-phosphate dehydrogenase  
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(GAPDH) were used as a control.  Preliminary investigation indicated that 27 PCR cycles in a 
final volume of 25 µl, using Taq DNA polymerase (Amersham Biosciences Baie d’Urfe, PQ) 
with a 58 C annealing temperature, addressed the linear portion of the amplification curve for 
both SR-BI and GAPDH.  Semi-quantitative PCR amplification for SRB1 and GAPDH in luteal 
tissues and granulosa cells was performed tissues from 3-5 animals, and products were resolved 
on 1 % agarose gel using 1 % ethidium bromide.  Optical densities were analyzed using Alpha-
imager densitometer (Alpha Innotech, San Leandro, CA). 
Western blot analysis 
One mg of tissue as described above was homogenized using 300 µl protein loading 
buffer containing ß-mercaptoethanol and maintained at –20 C until analysis.  Protein 
concentrations were determined by Bradford (Bio-Rad) assay, and an aliquot of 30 µg of protein 
was loaded per well.  Blots were electrophoretically separated using one-dimensional 10% SDS-
PAGE at 105 Volts.  High molecular weight standards (Amersham Pharmacia, Piscataway, NJ) 
were used as reference.  Resolved proteins were transferred to a 0.45 µm nitrocellulose 
membrane (Amersham Pharmacia Biotech, Arlington Heights, IL), and stored at 4 C overnight.  
Membranes were washed with distilled water and stained with Ponceau solution, washed again in 
0.1% Tween in Tris-buffered saline (TTBS: 100 mM Tris, 0.9% sodium chloride from Sigma, 
pH 7.5) and blocked with 1% BSA in TTBS.  A polyclonal SR-BI first antibody (Novus 
Biological, Inc. Littleton, CO) was added at 1:1000  final concentration, followed by 2 h 
incubation and a second antibody, anti-rabbit IgG, labeled with horseradish peroxidase 
(Amersham Biosciences UK Limited, Buckinghamshire, UK) was applied at 1:10000 over 30 
min.  We further examined SR-BII, a splice variant of SR-BI by using a polyclonal antibody 
(Novus Biological, Inc. Littleton, CO) at 1:1000.  The LDL receptor was evaluated by means of 
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a monoclonal antibody (Abcam Inc. Cambridge, MA), at 1:1000 concentration, incubated for 2 
h, and a second antibody, rabbit anti-mouse IgG conjugated to horseradish peroxidase (EMD 
Biosciences Inc., San Diego, CA) was used at 1:10000 over 30 min.  As a control, -tubulin was 
probed using a monoclonal antibody developed by the Developmental Hybridoma Bank (Iowa 
City, IA) at 1:1500 concentration under conditions of incubation for 2 h; and the same second 
antibody and incubation time used for LDL receptors was applied.  All incubations were carried 
out at room temperature.  Membranes were rinsed and abundance of all proteins were detected 
with chemiluminescent substrate (Pierce Biotechnology, Inc. Rockford, IL.), and blots were 
exposed to Kodak (Rochester, NY) photographic films.  The optical density of the protein band 
was quantified by scanning with an Alpha-image densitometer. 
Immunoflourescence  
Ovaries, follicles and CL were fixed in Zamboni’s solution, embedded in paraffin, and 
sectioned at 6 µm.  Tissue sections were rehydrated and, for antigen recovery, boiled in 10 mM 
sodium citrate (pH 6.0) for 10 min.  Slides were then rinsed once in cold (4 C) PBS (5 min), 
blocked for 20 min with 1 % BSA, incubated over 2 h at room temperature using the SR-BI 
polyclonal antibody at 1:50.  Tissues were rinsed twice in PBS and incubated for 30 min with a 
second antibody labeled with a cyanine dye (Cy3, Biocan Scientific Inc. Mississauga, ON).  
Nuclei were stained with 1:1500 4’diamino-2-phenyindole dilactate, (DAPI, Sigma).  All 
procedures were performed at room temperature.  Slides were mounted in Permafluor (Thermo 
Shando, Pittsburgh, PA,).   
Deglycosylation of SR-BI 
To establish the basis for SR-BI forms of variant molecular weight, CL III tissues were 
subject to in vitro deglycosylation using endoglycosidase H (Endo H) and N-glycosidase F 
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(PNGase, both from New England BioLabs Ipswich, MA), (0.8 to 1 mg) were lysed in 300 µl of 
protein loading buffer plus ß-mercaptoethanol (14.3 µl/ml), and 50 mg aliquots of total protein 
(evaluated by Bradford) were denatured at 100 °C over 5 min.  Then, 1/10 volume of G5 buffer 
(0.5 M sodium citrate, pH 5.5 at 25 °C) and 5 units of Endo H were added, and the mixture was 
incubated overnight at 37 °C.  For PNGase digestion 50 mg total protein was treated with 5 units 
of the glycosidase in ß-mercaptoethanol and G7 buffer followed by overnight incubation at 37 
°C.  The undigested sample (control) was incubated without enzyme.  Samples were subjected to 
Western blot analysis in one-dimensional 8 % SDS-PAGE at 105 Volts.  High molecular 
standard weight protein markers (Amersham) were used as reference.  Samples were evaluated in 
triplicate.  
Statistical analyses 
SR-BI mRNA optical density was standardized by comparison to GAPDH.  For SR-BI 
protein expression, optical density data were transformed using square root to obtained normality 
of distribution, transformed data were analyzed by split plot ANOVA.  SR-BI protein 
deglycosylation was tested using Chi square procedures.  LDLR and SR-BI protein optical 
density data were transformed using square root and analyzed 2 X 2 factorial design ANOVA. 
The level of significance for all analyses was P < 0.05. 
 
RESULTS 
Expression of SR-BI in granulosa cells from ovarian follicles and corpora lutea 
 RT-PCR analysis revealed that SR-BI mRNA was present in granulosa cells aspirated 
from all classes of ovarian follicles collected, and did not differ in abundance with the stage of 
follicle development (Fig. 1).  Luteal transcript abundance was consistently 1.5 to 2.0 fold 
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greater, and did not differ through the luteal phase of the estrous cycle (Fig. 1).  SR-BI protein 
quantification of immunoblots indicated that granulosa cells of all follicles express both the 57 
and 82 kDa forms of SR-BI (Fig. 2).  The abundance of the lower molecular weight form 
differed from barely detectable in small follicles to more pronounced in corpora lutea.  In 
contrast, the 82 kDa form, also barely detectable in follicles, is robustly expressed in corpora 
lutea.  The relative abundance was consistent with the pattern of mRNA expression, in that it was 
more strongly expressed in corpora lutea relative to follicles (Fig. 2).  The total immunoreactive 
protein increased 6-7 fold with luteinization, while the proportion of 57 kDa form declined from 
an average of 10 % in follicles to 5 % in corpora lutea.  
Subsequent experiments were undertaken to determine whether the difference between 
the 82 and 57 kDa forms was related to the carbohydrate moiety of the glycoprotein.  Fig. 3 
depicts the effects of digestion of protein extracts of midcycle corpora lutea (CL-III) with Endo-
H, a glycosidase that cleaves mannose and some hybrid oligosaccharides from N-linked 
glycoproteins, and with PNGase, an amidase that cleaves N-linked carbohydrates between the 
innermost GlcNAc and asparagine residues (14).  Endo H treatment reduced the 82 kDa form 
substantially, to a consequent 68 kDa form, with no apparent effects on the 57 kDa version, 
suggesting partial deglycosylation (Fig. 3).  In samples subject to PNGase digestion, the 82 kDa 
form was entirely eliminated and only the 57 kDa form persisted (Fig. 2).   Together, these 
digestions indicate that the difference between the two forms of SR-BI in corpora lutea (Fig. 2A) 
is based on glycosylation of the 82 kDA species. 
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Changes in cholesterol importation receptor abundance and localization during the peri-
ovulatory and luteinization periods 
Immunolocalization was employed to further characterize the differences in cholesterol 
transport mechanisms between follicular and luteal cells.  As depicted in Fig. 4, the SR-BI signal 
is present throughout the cytoplasm in theca and granulosa cells, while it is restricted to the 
periphery of luteal cells.  Based on this observation, we examined the changes of SR-BI 
abundance and localization during the ovulatory process in the pig (Fig. 5).  In the largest 
follicles of untreated pigs, SR-BI distribution conformed to the observations in Fig. 4, with 
cytoplasmic expression in the theca and granulosa cells, the latter much reduced compared to the 
former.  The first 24 h after the ovulatory stimulus were characterized by a modest increase in 
cytoplasmic SR-BI expression in granulosa cells that became more intense as ovulation 
approached (30 and 38 h, Fig. 5A).  Early corpora lutea, (CL-I, 24-48 h after ovulation) display 
both cytoplasmic and membrane localization of SR-BI, while in later stages, the signal was most 
commonly found on the periphery of the cells (Fig. 5B).  
There are multiple mechanisms of cholesterol supply to steroidogenic tissues, and 
perhaps the second most significant in the ovary is LDL receptor-mediated importation (15).  It 
was therefore of interest to establish whether concurrence, complementarity or some other 
mechanism characterized the cholesterol import receptors during transformation of the porcine 
follicle into the corpus luteum.  Immunoblotting revealed that the LDL receptor was highly 
expressed in granulosa cells of small, medium and large follicles (Fig. 6A and 6B) but the signal 
became undetectable with luteinization.  Concurrent analysis of SR-BI demonstrated a pattern of 
expression identical to that displayed in Fig. 2 (Fig. 6A and 6B), such that the 82 kDa form was 
virtually absent from follicles and was acquired by the CL following ovulation.  Together these 
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results indicate a temporal sequence in expression of the receptors and complementarity between 
the two extracellular cholesterol supply processes during the process of CL formation.  
Alternative splicing of the SR-BI transcript results in a second form of the protein with a 
different carboxyl-terminal cytoplasmic tail, apparently conferring predominant intracellular 
expression (5).  As this splice variant represents some 10-15 % of SR-BI in the liver (27), we 
examined its abundance through the luteal phase by immunoblotting.  The results (Fig. 6C) 
demonstrate that this isoform is present in the CL, but that its relative abundance does not vary 
across the luteal phase of the estrous cycle.  
Gonadotropin induction of the pattern of cholesterol importation in vitro 
We then addressed the mechanism by which these modifications in the cholesterol 
acquisition system might be controlled.  We first employed  an in vitro model of follicular 
function in which whole follicles were placed in organ culture for periods up to 30 h.  Granulosa 
cells harvested from follicle culture under conditions expected to induce luteinization, i.e. the 
presence of 10 % serum, displayed the expected low level of SR-BI and elevated LDL receptor 
protein abundance (Fig. 7).  In granulosa cells aspirated from follicles incubated with serum, but 
not treated with gonadotropin, there was an increase in SR-BI expression over 12 h relative to 
freshly isolated granulosa cells.  Treatment with the ovulatory stimulus, in the form of 100 and 
500 iu hCG, provoked significant increases in the expression of this receptor in the granulosa cell 
compartment (Fig. 7).  These changes persisted through 30 h of treatment.  In contrast, and as 
expected, LDL receptor abundance was greatest in granulosa cells aspirated from newly 
collected follicles (Fig. 7).  Significant declines were induced by both doses of hCG at 12 h, and 
these persisted through 30 h, recapitulating the observations of luteinization in vivo.  
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To complement whole follicle studies, and to determine to what extent the increases in 
SR-BI expression were related to post-transcriptional changes, the model of transcriptional 
inhibition with Act-D during in vitro luteinization of isolated granulosa cells (18) was employed.  
In cells incubated with LH, there was an approximate doubling in SR-BI transcript abundance at 
24 and 48 h relative to untreated control (Fig. 8A).  A similar increase in protein was observed at 
24 h, while there was an approximate 5-fold augmentation at 48 h (Fig. 8B).  Act-D treatment 
(Fig. 8) obliterated both the mRNA and protein signals, indicating that increases in abundance of 
the message and protein are due to new transcription, rather than to post-transcriptional 
regulation.  Progesterone analysis (Fig. 8C) demonstrated that LH induced increases in the 
accumulation of this steroid at 24 h relative to control, an effect that was abrogated by Act-D 
treatment.  At 48 h, progesterone accumulation was increased in both control and LH treated 
cultures.  There was substantial accumulation in the Act-D treated cells, indicating that the cells 
remained alive and steroidogenic, in spite of the absence of significant amounts of SR-BI.  
We further examined whether lipoprotein content of the medium influenced the 
expression of SR-BI by incubation with either FBS or lipoprotein depleted FBS (FBLDS).  The 
results (Fig. 9), indicate that, while the overall accumulation of progesterone when FBLDS was 
present, relative to FBS, no evidence that this treatment affected SR-BI expression, in either 
transcript or protein abundance. 
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DISCUSSION  
 The mammalian corpus luteum is the product of extensive tissue remodeling of the 
ovarian follicle that begins with the ovulatory stimulus.  Its presumed evolutionary advantage, 
and thus its function, is the large-scale secretion of the progestins required for viviparity.  The 
principal source of cholesterol substrate for this steroid output is importation from extracellular 
sources (15, 20).  The goal of this investigation was to examine the process of luteinization, in 
terms of the changes in cholesterol importation mechanisms.  
Previous studies in the rat suggested that, while SR-BI was present in the theca 
compartment, it was absent from the granulosa cells of ovarian follicles (12).  In contrast, we 
found transcripts to be present and low levels of protein detectable in granulosa cells of all 
classes of follicles from the porcine ovary.  Immunocytochemical observations in the present 
study indicate that the localization of SR-BI expression in granulosa cells is, at least in part, 
cytoplasmic, even up to the period of peri-ovulatory differentiation.  This distribution is 
surprising, and perhaps counterintuitive, given the high concentrations of HDL in porcine 
follicular fluid (7), and the indications that the function of SR-BI as the HDL receptor requires 
its insertion in the plasma membrane (24).  It is  known that porcine granulosa cells do not 
synthesize steroids from cholesterol, due the absence of steroidogenic acute regulatory protein 
(StAR) prior to the onset of luteinization (8, 22) and low level expression of cytochrome 450side 
chain cleavage (CYP11A) (6).  Together these observations suggest that HDL uptake is not an 
essential element of follicular granulosa cell function.   
Our findings demonstrate that, in the pig ovary, there are substantial increases in 
abundance of both SR-BI message and protein associated with luteinization.  Qualitative 
immunohistochemical observations suggest that this is a gradual change, beginning during the 
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first 24 h after the ovulatory stimulus, and continuing through luteinization.  The molecular and 
microscopy data in the porcine model concur with observations of in situ hybridization findings 
in the rat ovary, where there is a progressive increase in signal abundance and intensity as the 
luteinization process ensues (11) and with studies of rat granulosa cells in vitro where SR-BI 
transcript and protein both gradually increase during luteinization (4).  The latter authors 
demonstrated that SR-BI expression was essential for the uptake of esterified cholesterol by 
luteinized granulosa cells (4).   
Functional luteal regression, i.e. the reduction in steroidogenic capacity, precedes 
structural regression in most species (25).  The continued expression of SR-BI in regressed CL 
observed in the present investigation suggests uncoupling of the processes of luteal 
steroidogenesis and the cholesterol intake at the end of the luteal phase.  This is in contrast to 
intracellular steroid transport mechanisms, including the steroidogenic acute regulatory (21) and 
the Niemann-Pick C-1 proteins (9) that decline rapidly following treatment with a luteolytic 
stimulus.   
From these findings we infer that, during the process of granulosa cell remodeling into 
large cells of the CL (19), the SR-BI signal is translocated to the cell periphery, and presumably 
to the cell surface, at a site in which it can function in cholesterol exchange.  There is a large-
scale increase in the quantity of the 82 kDa form of the protein accompanying luteinization, 
including a doubling in its abundance during the progression from the post-ovulatory (CL-I) to 
the midcycle (CL-II and III) corpus luteum.  Follicle and isolated cell culture experiments 
indicate that the expression of SR-BI is induced by gonadotropin treatment, arguing that this 
event is specific to the luteinization process.  The proportion of total immunoreactivity in the 
larger molecular weight form was double in luteal cells when compared to granulosa cells, 
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indicating that differentiation involves an alteration in or upregulation of the glycosylation 
process.  This is at odds with the observation that N-glycosylated residues are co-translationally 
incorporated into the protein during its synthesis (24), but may be a further reflection that the 
granulosa cell version of the receptor is nonfunctional prior to the ovulatory stimulus.  
Confirmation awaits further investigation.  
A further interesting finding is that HDL and LDL receptors display a complementary 
pattern of expression during ovarian follicle remodeling.  The granulosa cell expression the LDL 
receptor is marked and invariable in the developing follicle in spite of the apparent absence of 
LDL in porcine follicular fluid (7).  The present investigation indicates that LDL receptor is lost 
during luteinization and that the signal is virtually undetectable in the CL.  The pattern of SR-BI 
expression is reciprocally related to that of the LDL receptor, at lowest levels in follicle 
granulosa cells and highest in the CL, in spite of elevated concentrations of HDL in follicular 
fluid (7).   
The question that arises is whether the dramatic switch in cholesterol uptake from LDL 
receptor to SR-BI is essential, or whether the two importation strategies are redundant in CL 
function.  Mice bearing an inactivating mutation of the SR-BI gene, while infertile, are capable 
of forming morphologically functional corpora lutea that produce peripheral progesterone at 
concentrations that do not differ from their wild type counterparts (26).  Ovaries from SR-BI null 
mice transplanted to ovariectomized, immunocompromised mice supported ovulation and 
gestation (16), further indicating normal luteal function.  In fact, sterility in these animals has 
been recently attributed to dyslipedemia, resulting the absence of normal bi-directional flux of 
HDL in the liver (30), rather than luteal insufficiency.  Nonetheless, there are noticeable 
differences between the SR-BI knockout and wild type mice in the Oil-Red-O staining of the 
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corpora lutea, indicating reduction in intracellular cholesterol stores in the former (26).  Recent 
studies suggest that HDL borne cholesterol and cholesterol derived from de novo synthesis 
contribute approximately equally to the steroid substrate pool in the mouse ovary, while LDL 
cholesterol has only a minor role in ovarian steroidogenesis (29).  It is not clear whether de novo 
cholesterol synthesis or LDL receptor-mediated importation compensate for the absence of the 
HDL cholesterol delivered via SR-BI in the mouse.   
Less is known about the relative contribution of cholesterol sources in other species.  
Herein we present evidence to demonstrate that SR-BI, the HDL receptor is strongly expressed 
during luteinization and this expression is provoked by the ovulatory stimulus.  Further, in vitro 
studies indicate that SR-BI is induced by gonadotropins through new gene transcription, and 
appears that this process is not influenced by lipoprotein availability.  This implicates HDL 
cholesterol as the major source of substrate for luteal steroidogenesis in the pig.  
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FIGURE LEGENDS 
Figure 1. Follicles and corpora lutea express SR-BI transcripts. (A)  Representative RT-PCR 
analysis revealing the occurrence and relative abundance of SR-BI transcripts in small follicles 
(SF, < 3mm diameter), medium follicles (MF, 4-7 mm) and large follicles (LF, >8 mm) and 
corpora lutea (CL) across the progression of  the luteal cycle (CL-I to CL-IV).  GAPDH has been 
employed as a control. (B)  Mean ± SD of SR-BI transcript abundance relative to GAPDH for 
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five follicles and five CL at each stage of development.  Means bearing different superscripts are 
significantly different at p< 0.05)  
Figure 2.  Developmental sequence of SR-BI protein abundance in ovarian tissues.  (A) 
Representative immunoblot demonstrating the two species of protein (82 kDa and 57 kDa) 
detected in porcine ovarian tissues.  Tubulin served as loading and constitutive control.  Follicle 
and CL classification as in the legend to Figure 1. (B)  Mean ± SD of the relative abundance of 
the 87 kDa version SR-BI in a series of five follicles and five corpora lutea at each stage of 
development.  (C) Mean ± SD relative abundance of the 57 kDa form of SR-BI relative to 
tubulin.  Means with different superscripts are different a p<0.05.  
Figure 3.  Effects of enzymatic deglycosylation on SR-BI from corpora lutea as revealed by 
immunoblot.  An aliquot of 50 µg of luteal protein extracts prepared was digested overnight at 
37 °C with endoglyosidase-H (Endo-H) or N-glycosidase F (PNGase).  Immunoblots 
demonstrate the relative abundance of the products of digestion in a representative experiment.  
Tubulin was employed as a control for loading.  The graph  indicates the percentage of the total 
sample found in each molecular weight category between control and digested protein samples 
for each of the enzyme treatments and is representative of three replications of the trial.   
Figure 4.  Immunocytochemistry demonstrating the divergent cellular localization of SR-BI 
in cells from compartments of the porcine ovary.   The photomicrographs depict 
representative sections of 3-5 mm follicles showing the theca and granulosa component, along 
with a representative section from a midcycle CL.  Indirect localization was employed using Cy3 
as the fluorescent signal for SR-BI, and DAPI as a nuclear marker.   
Figure 5. Changes in cellular localization of SR-BI during the periovulatory and luteal 
phases of the estrous cycle in the pig.  Follicular and corpus luteum SR-BI membrane and 
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cytoplasmic expression. (A).  Representative sections demonstrating SR-BI expression and 
localization in follicles at 0, 24, 30 and 38 h after hCG administration.  As in Fig. 4, the Cy3 
marker indicates SR-BI, localization, DAPI the nuclear signal.  (B).  Changes in the SR-BI signal 
across the course of luteal development and during luteal regression in representative corpora 
lutea, classified according to morphological characteristics.  T, theca cells, G, granulosa cells, 
BM, approximate localization of the basement membrane separating the theca and granulosa 
compartments.  
Figure 6.  Comparison of the abundance of the LDL receptor and SR-BI in follicles and 
corpora lutea by immunoblot.  Pig follicles and corpora lutea were classified as in the legend 
to Fig. 1.  (A)  Representative Western blot demonstrating the occurrence of LDL receptor 
(LDLR) in the follicular granulosa cells but not corpora lutea, while SR-BI was found, as in 
previous figures, primarily in corpora lutea.  Tubulin expression was used as loading control.  
(B) Mean density of protein bands showing reciprocal expression of the LDL receptor (high in 
follicles, low in CL, p<0.01) and SR-BI (low in follicles, high in CL, p<0.01) in tissues 
representing the events of folliculogenesis and the luteal phase in the pig.  (C)  Immunoblots 
representative of analysis of porcine corpora lutea across the luteal phase demonstrating the 
relative abundance of SR-BII, a splice variant of SR-BI.   
Figure 7.  Induction of the reciprocal expression of the LDL receptor and SR-BI in 
granulosa cells from porcine follicles in culture.  Whole follicles between 3.5 and 5 mm in 
diameter were dissected from ovaries, incubated for 12h, followed by addition of hCG (100 IU 
or 500 IU) and incubation until termination of the cultures at 12 or 30 h after initiation of 
gonadotropin treatment.  The granulosa cells were aspirated and subjected to Western analysis.  
(A) is a representative immunoblot while (B) and (C) depict the mean ± SD of abundance of 
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each receptor relative to tubulin in triplicate incubations.  Means bearing different superscripts 
are different at p<0.05. 
Figure 8.  Induction of SR-BI expression in isolated luteinized porcine granulosa cells with 
100 ng/ml luteinizing hormone (LH) and the effects of transcriptional blockade with 
actinomyocin-D (Act-D).  Granulosa cells isolated from 3-5 mm porcine follicles were treated 
with culture medium alone or medium plus 5 µg/ml Act-D.  After 24 h medium was changed and 
fresh medium or medium + 100 ng/ml luteinizing hormone (LH NIH USDA), was added.  
Cultures were terminated 24 or 48 h later and SR-BI transcript (Panel A) and protein (Panel B) 
abundance were determined.  Progesterone accumulation in culture medium was determined by 
radioimmunoassay (Panel C).  Bars represent means ± SD from three replicate experiments.  
Means bearing different superscripts are different at p<0.05.   
Figure 9.  The effects of lipoproteins in culture medium on expression of SR-BI by 
luteinized porcine granulosa cells.  Cells, isolated from 3-5 mm porcine follicles were cultured 
for 48 h in medium containing 10 % fetal bovine serum (FBS) or 10 % fetal bovine lipoprotein-
depleted serum (FBLDS).  SR-BI expression was determined by (A) PCR amplification for 
transcript abundance and (B) immunoblot analysis for protein expression.  Progesterone 
accumulation in medium (C) was determined by radioimmunoassay.  Data are means ± SD from 
three replicate experiments, and means with different superscripts indicate difference at p<0.05.  
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CHAPTER TWO 
 
In the previous chapter, it was demonstrated that, in the pig model, the expression of SR-
B1 characterizes luteinization.  Although there is a low level of expression of the transcript and 
the protein in granulosa cells, there is a major shift increase as the CL develops, indicating the 
importance of HDL transport to luteal function.  The experiments in Chapter Two were 
developed to further examine this phenomenon in the mouse CL, first by characterizing the 
pattern of expression of SR-B1, then by exploration of the consequences of null mutation of the 
SR-B1 gene on luteal structure and function. 
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ABSTRACT 
 During luteinization, bulk cholesterol uptake to ovarian cells from blood high-density 
lipoproteins (HDL) is achieved by scavenger receptor-BI (SCARB1).  The expression of 
SCARB1 was detected in the cytoplasm and periphery of theca, granulosa and cumulus cells of 
developing follicles and increased dramatically in corpora lutea during the mouse estrous cycle.  
Further, SCARB1 expression is associated with granulosa cell differentiation and is independent 
of ovulation, as indicated by blockade of ovulation with a prostaglandin synthase-2 inhibitor, 
meloxicam.  The resultant follicles displayed entrapped oocytes in unexpanded cumulus 
complexes while the granulosa layer expressed SCARB1 and morphology characteristic of 
luteinization.  To further explore mechanisms of cholesterol supply to ovarian steroidogenesis, 
we examined mice bearing null mutation of the scarb1 gene (SCARB1-/-).  The ovaries from 
SCARB1-/- mice displayed small corpora lutea, large follicles with thecal hypertrophy and 
follicular cysts with blood filled cavities. Plasma progesterone concentrations were decreased 
50% in mice bearing the null SCARB1 mutation. SCARB1-/- mice were treated with a 
combination of 20 µg/g BW of mevinolin (an inhibitor of 3-hydroxy-3-methylglutaryl CoA 
reductase, HMGR) and 100 µg/g BW of chloroquine (an inhibitor of lysosomal processing of 
low density lipoproteins).  Serum progesterone was further reduced by this treatment (43% in 
wild type and 30% in SCARB1-/- mice ).  HMGR protein expression was increased in SCARB1-/- 
mice, regardless of CHLORO-MEV treatment.  It was concluded that theca, granulosa and 
cumulus cells express SCARB1 during follicle development, but maximum expression depends 
on a luteinization stimulus.  Knockout of SCARB1-/- leads to ovarian pathology and sub-optimal 
luteal steroidogenesis.  Further perturbation of cholesterol de novo synthesis and uptake from 
LDL leads to a greater reduction, but not to complete impairment, of luteal function.  We 
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conclude that SCARB1 expression is an important, but not essential, factor in maintaining 
ovarian cholesterol homeostasis and steroid synthesis.   
INTRODUCTION 
 The cholesterol substrate requirement for most tissues to accomplish steroidogenesis 
exceeds the capacity for de novo synthesis of this sterol, and the principal means of 
augmentation of the supply is by importation of lipoprotein bound cholesterol [1].  Low density 
lipoproteins (LDL) enter cells by receptor-mediated endocytosis of LDL and the LDL receptor 
(LDLR) [2].  High density lipoproteins interact with a membrane protein known as scavenger 
receptor-B1 (SCARB1) to effect the selective uptake of cholesterol esters from the HDL 
molecule into cells and the bi-directional transfer of free cholesterol to and from the cell [3].  The 
relative contribution of LDL and HDL to the steroidogenic substrate pool varies among species, 
and may vary among tissues within a species.  One of the most active steroidogenic tissues is the 
corpus luteum (CL), formed from the components of the follicle following ovulation [4].   In 
humans, circulating LDL is believed to be the major source of cholesterol for luteal steroid 
synthesis, but it has been shown that luteinized human granulosa cells can derive cholesterol 
esters from selective uptake via the HDL pathway [5].  The HDL pathway appears to 
predominate in the CL of rodents [1] and SCARB1 is expressed in theca and luteal cells of the 
rat ovary [6].  SCARB1 expression in primary cultures of rat granulosa cells is tightly coupled 
with the uptake of cholesterol esters, again suggesting that it is the major pathway for 
importation in this tissue [7]. There is a low level of expression of SCARB1 in mouse granulosa 
cells [8], and recent studies of luteinization in the pig demonstrated insignificant expression of 
SCARB1 in the granulosa cells of the follicle [9].  The latter study revealed extensive 
upregulation of SCARB1 in the CL following ovulation, with a high level of expression 
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persisting through the luteal phase.  In the macaque, the ovulatory stimulus causes a rapid 
increase in expression of both SCARB1 and LDLR, but only LDL can augment steroidogenesis 
after 24 h in vitro [10]. 
 The inactivating mutation of SCARB1 in the mouse results in infertility, in the presence 
of a normal rate of ovulation [11], and apparently normal capacity to produce progestational 
steroids [12].  The observation that non-viable oocytes are produced has led to the implication 
that the ovulatory process itself is disrupted in some way [11, 12].  It is intriguing that targeted 
overexpression of SCARB1 in the liver rescues fertility to near wild type levels [13] although 
mechanisms remain unclear.  Further, if the major supply of cholesterol for steroidogenesis in the 
CL is HDL imported via SCARB1 in mice, the means by which the ovary in the SCARB1 
knockout mouse produces a functional CL remains unresolved.   
 Given the importance of SCARB1 to steroidogenesis and ovarian function, we explored 
the expression of SCARB1 in the ovary through the estrous cycle in adult mice and following 
blockade of ovulation in gonadotropin-stimulated immature mice.  Finally, to determine possible 
associations of form and function in the absence of a functional HDL importation system, we 
examined the morphology of ovarian structures and responses to pharmacological perturbations 
of the cholesterol metabolism in mice bearing inactivating mutation of SCARB1.  
MATERIALS AND METHODS 
All animal experiments were approved by the University of Montreal Animal Care 
Committee and conducted according to guidelines of the Canadian Council of Animal Care. 
Experiment 1:  Our initial interest was to determine patterns of expression of SCARB1 in the 
ovary during final stages of follicular development and luteinization.  Stages of the estrous cycle 
were determined in mature wild type (WT) mice of mixed C56/B6 and Balb/c lineage by 
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examination of exfoliative cytology of the vagina.  To determine the distribution of SCARB1, 
ovaries were collected following euthanasia from three animals at each stage, dissected free from 
surrounding tissues under a stereoscope, fixed in paraformaldehyde and embedded in paraffin 
using standard procedures.  Ovarian tissue- and cell-specific localization of SCARB1 was 
verified by fluorescence immunohistochemistry.  Briefly, paraffin sections of ovaries were 
rehydrated, boiled in 10 mM sodium citrate (pH 6.0) for 20 min and cooled to room temperature 
(RT).  Subsequently, sections were blocked in PBS containing 5 % BSA for 30 min at RT, 
incubated with rabbit polyclonal anti-mouse SCARB1 (Novus Biologicals, Littleton, CO), 
diluted 1:50 in PBS containing 5 % BSA overnight at 4°C, washed, incubated with Cy3-
conjugated goat anti-rabbit IgG (Jackson Immunoresearch Lab., Inc.), diluted 1:400 in PBS for 1 
h at RT.  Slides were then washed, and sections counterstained with 4',6-diamidino-2-
phenylindole (DAPI, Sigma, St. Louis, MO), diluted 1:1000 in PBS, for 5 min.  Slides were 
mounted in Permafluor (Lab Vision Corp.; Fremont, CA).  Ovarian distribution of SCARB1 was 
observed by confocal microscopy using the Olympus Fluoview 1000 system and Fluoview 
version 1.7 software.  Laser sources of 543 nM and 405 nM were employed for detection of CY3 
and DAPI signals, respectively.  For a given fluorochrome (i.e., CY3 or DAPI), photomultiplier 
voltage, laser power, pinhole aperture, time of acquisition and image resolution were maintained 
constant for all confocal images.  The Kalman filter mode was used for all image acquisition.  
For high magnification images (600 x) of follicles, “stacks” of five subsequent images, 1.42 mm 
thick each, were obtained.  Then, for each particular cell type (i.e., theca, mural granulosa or 
cumulus), the image within the stack showing the strongest signal was selected for analysis.  
Experiment 2: To determine whether the elevated expression of SCARB1 that accompanies 
luteinization depends on ovulation, immature WT female mice received IP injections of equine 
 89
chorionic gonadotropin (eCG; 5IU) followed by human chorionic gonadotropin (hCG; 5IU) 48 h 
later to induce follicular development and ovulation.  At 4 h prior to the hCG injection, animals 
received 0 or 6 mg/g BW meloxicam [MEL; prostaglandin synthase-2, PTGS2) activity 
inhibitor; Sigma, St. Louis, MO] to block ovulation [14].  Ovaries and oviducts were collected 
18, 24 or 36 h after the hCG injection (n=3 animals/time point) and separated by dissection.  
Oviducts and the right ovary of each mouse were embedded in paraffin as described for 
Experiment 1.  Morphology of ovarian structures and presence of ovulated oocytes in oviducts 
were observed by light microscopy in hematoxlyn/eosin (HE) stained tissue sections. Ovarian 
tissue- and cell-specific localization of SCARB1 was verified by fluorescence 
immunohistochemistry and confocal microscopy, as described for Experiment 1.  The left ovary 
of each mouse was snap frozen in liquid nitrogen and stored at -80C until RNA extraction and 
real-time PCR (qPCR) analysis of SCARB1 mRNA abundance.  Total RNA was isolated from 
each previously frozen whole ovary using a Qiagen RNeasy Mini Kit (Qiagen, Valencia, CA) as 
per manufacturer’s instructions.  For each sample, concentration of isolated total RNA was 
estimated from the absorbance measured at 260 nm using a a NanoDrop apparatus (NanoDrop 
Technologies, Wilmington, DE) and the volume of extract containing 1 µg RNA was submitted 
to DNAse treatment and reverse transcription.  The resulting cDNA was used in subsequent 
qPCR reactions using a 7300 Real-time PCR system (Applied Biosystems, Foster City, CA) 
conducted in triplicate and each reaction contained 10 µl Power SYBR Green PCR Master Mix 
(Applied Biosciences, Warrington, UK), 2 µl of a sense-antisense primer mix, 2 µl autoclaved 
ddH2O and 6 µl cDNA sample, for a final volume of 20 µl.  Common thermal cycling settings 
were use to amplify each transcript (2 min at 50C, 10 min at 95C, then 40 cycles consisting of 15 
sec at 95C and 60 sec at 60C).  Melting-curve analyses were performed to verify product 
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identity, adding a dissociation step to the PCR run (15 sec at 95C, 60 min at 60C, 15 sec at 95C 
and 15 sec at 60C).  The sense and anti-sense sequences of primers for SCARB1 were 5’-
tctggcgctttttctatcgt-3’ and 5’-acggcccatacctctagctt-3’ [15], used in a final concentration of 300 
nM each.  The ribosomal protein L19 (RPL19) was used for the normalization of SCARB1 
abundance.  The RPL19 primer sequences for sense and antisense primers were 5’- 
CTGAAGGTCAAAGGGAATGTG-3’and 5’-GGACAGAGTCTTGATGATCTC-3’ [16] and 
they were each used in a 300 nM final concentration.  To test the efficiency of amplification of 
primers of each gene, a cDNA pool was made using equal volumes of cDNA solution from each 
sample.  The cDNA pool was serially diluted in autoclaved ddH2O from 1:7.5 to 1:240 and 
samples analyzed using the qPCR procedure described above.  Efficiency of amplification of 
each sample was estimated using the LinReg software [17] and the efficiency of amplification of 
the curve obtained from the serially diluted cDNA calculated from the slope of the curve 
[http://efficiency.gene-quantification.info/].  Calculated efficiencies ranged between 90 and 
110% and were therefore considered adequate.  Next, cDNA from each sample was diluted 1:15 
in autoclaved ddH2O and analyzed by qPCR for RPL19 and SCARB1.  Relative abundance of 
SCARB1 transcripts was calculated by the Ct method corrected by the efficiency of 
amplification, as described by Pfaffl [18].  The relative abundance of SCARB1 was analyzed by 
ANOVA using the procedure GLM from the software SAS [19].  Independent variables were 
treatment (placebo or MEL), time after hCG injection (18, 24 or 36 hours) and the treatment by 
time interaction. 
Experiment 3:  Given the central role of SCARB1 in ovarian steroidogenesis, a SCARB1-/- 
mouse model provided by Dr. M. Krieger [11], was used to examine the effects of SCARB1 
absence on ovarian morphology.  Development and ovulation of follicles in adult, wild type 
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(WT) and SCARB1-/- mice were stimulated with eCG and hCG injections 48 h apart.  
Cholesterol supply was further perturbed by pharmaceutical intervention with de novo synthesis 
and delivery of cholesterol from LDL.  At 4 h prior to hCG injection, animals were divided to 
receive vehicle or a combination of 20 µg/g BW mevinolin (MEV), an inhibitor of 3-hydroxy-3-
methyl-glutaryl-CoA reductase (HMGR; Sigma, Fair Lawn, NJ) and 100 µg/g BW of 
chloroquine (CHLORO; Science Lab. Inc., Kingwood, TX)), a weak base that interferes with 
cholesterol efflux from lysosomes, thereby inhibiting intracellular delivery of cholesterol from 
LDL [20, 21].  The experiment took the form of a 2x2 factorial (n=3 per group).  Ovaries and 
blood were collected 18 h after the hCG injection, the former fixed in Bouin’s solution for 24 h 
and embedded in paraffin, as described earlier.  Morphology of ovarian structures was observed 
by light microscopy both in HE- and periodic acid-Schiff (PAS)-stained tissue sections. To 
verify whether inhibiting cholesterol sources affected ovarian tissue- and cell-specific 
localization of SCARB1 in WT mice, SCARB1 was identified by immunohistochemistry, as 
described for Experiment 1.  Because manipulating cholesterol sources was expected to alter 
expression of cholesterol synthesizing enzymes, ovarian abundance and distribution of HMGR 
was analyzed in all animals by immunohistochemistry.  The procedure was similar to described 
above for detection of SCARB1, except that a goat anti-human polyclonal antibody (Santa Cruz 
Biotechnology, Santa Cruz, CA), diluted 1:50 in PBS containing 5% BSA, and a CY3-
conjugated donkey anti-goat IgG antibody (Jackson Immunoresearch Lab., Inc.), diluted 1:400 in 
PBS were employed.  
Serum was separated from whole blood and progesterone concentrations in serum were 
evaluated by radioimmunoassay according to a protocol described previously [22].  
Concentrations of progesterone were analyzed by ANOVA using the procedure GLM from the 
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software SAS [19].  Independent variables were genotype (WT or SCARB1-/-), treatment 
(control or CHLORO and MEV combination) and the genotype by treatment interaction. 
   
RESULTS 
Experiment 1:  Immunohistochemical analysis revealed that SCARB1 was present in theca and 
granulosa compartments of large follicles and in CLs  (Figure 1).  Overall, SCARB1 expression 
appeared to increase as follicles developed from proestrus to estrus through the estrous cycle and 
expression was maximum following luteinization.  Punctate expression of SCARB1 was 
observed in theca, mural granulosa, cumulus, and luteal cells (Figure 2).  In all cell types, 
expression was observed throughout the cytoplasm and plasma membrane, but appeared absent 
from the nucleus.  Staining was more intense in the cytoplasm of luteal cells, and, given the 
larger volume of cytoplasm with respect to follicular cells, it was clear that SCARB1 protein 
expression per cell is greater in the cells of the CL. 
Experiment 2:  To further establish the expression patterns of SCARB1 and to determine the 
role of ovulation in the increase of the SCARB1 gene expression and immunoreactivity, we 
treated mice with the inhibitor of PTGS2 activity, MEL or with vehicle.  Histological analysis of 
the ovaries (Figure 3) and oviducts (data not shown) revealed that ovulation had occurred in all 
but a few large follicles in the vehicle treated animals by 18 h after hCG treatment.  The 
expected CL formation was evident in control animals at 24 and 36 h (Figure 3 A-C).  In 
contrast, the ovaries of mice treated with MEL displayed oocytes surrounded by compact layers 
of cumulus cells in follicles and no corpora lutea at 18 h after hCG treatment, antral follicles with 
entrapped oocytes and a few corpora lutea at 24 h, and oocytes entrapped in follicles with 
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reduced or absent antra at 36 h (Figure 3 D-F).  In the MEL treated mice, the granulosa layer at 
36 h after hCG appeared two or more fold thicker than in preovulatory follicles.  
 Ovarian abundance of SCARB1 mRNA (Figure 4) increased over time after hCG 
injection and was maximum at 36 hours (effect of time; P<0.01).  Increases occurred regardless 
of treatment (no treatment by time interaction; P>0.6), indicating that blocking ovulation did not 
interfere with whole ovary SCARB1 expression.  SCARB1 protein immunolocalization indicated 
that MEL treatment induced a redistribution of the SCARB1 signal among the different ovarian 
structures.  In the ovaries of vehicle treated mice, the signal for SCARB1 was found in the 
cytoplasm of granulosa cells at 18 h after the ovulatory stimulus and appeared not to vary at 24 h 
or 36 h (data not shown).  The granulosa cells maintained expression levels not different from 
proestrus, as seen in Figures 1 and 2.  In contrast, immunoreactivity in luteal cells increased 
across time Figure 5 A-C).  Indeed, by 36 h after the hCG injection, luteinization was indicated 
by increases in the cytoplasm to nuclear volume ratio and luteal cells displayed the luteal 
phenotype with respect to punctate distribution of SCARB1 immunoreactivity.  In ovaries from 
animals in which ovulation was blocked with MEL, the onset of increased expression of 
SCARB1 in non-ovulated follicles, as visualized by confocal microscopy, occurred at 18 h 
(Figure 5 D-F).  By 36 h, the cells in the thickened mural granulosa layer had taken on the luteal 
phenotype with respect to SCARB1 expression in spite of the absence of ovulation and 
entrapment of the oocyte.  In the few follicles that ovulated in MEL treated mice, the signal was 
similar to that seen in granulosa cells of the vehicle treated controls at 24 h (Figure 5G).  At 36 h 
the luteal phenotype was emerging, but appeared to be delayed relative to the control CL, in that 
there was an apparently lower expression of SCARB1 (Figure 5H).  
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Experiment 3: Previous reports suggest that there is no luteal defect in mice bearing null 
mutation of the SCARB1 gene (Rigotti 1997, Yesilaltay 2005).  In contrast, in the present study, 
we show that circulating progesterone levels in serum samples of superstimulated, ovulated mice 
were lower in SCARB1 knockout mice by approximately 50 % compared to the WT (P<0.01) 
during the luteal phase, (Figure 6).  It was therefore of interest to determine whether there are 
morphological correlates in ovaries of SCARB1-/- mice that might have caused the reduced 
progesterone output.   
The ovaries in the SCARB1-/- mice examined consistently displayed abnormal structures 
not found in WT ovaries (Figures 7 and 8).  The first was a blood-filled follicular cyst (Figure 
8A).  This structure was present in various degrees of enlargement throughout the SCARB1-/- 
ovaries.  At 18 h after hCG injection, approximately 6 h after expected ovulation, ovaries from 
SCARB1-/- mice contained structurally normal corpora lutea that were reduced in size relative to 
the same structures in WT mice (Figure 8B).  A common finding was the presence of follicle-
like structures that appeared to have two layers, with the outer comprising hypertrophied, luteal 
like cells and the interior resembling the granulosa cell compartment of a normal follicle (Figure 
8C).  To further define this structure, ovarian sections were stained with PAS to reveal 
polysaccharides.  This analysis revealed an intact basement membrane (Figure 8D) between the 
outer and inner compartments, leading to the conclusion that this structure is an intact  follicle 
with a hypertrophied theca compartment.  
We then attempted to further reduce the cholesterol pool in SCARB1-/- and wild type 
mice by blocking de novo synthesis with MEV and interdicting LDL processing with CHLORO.  
Overall, this treatment reduced circulating progesterone 42% (P<0.02).  Reduction was 43% in 
wild type mice and 30% in SCARB1-/- (Figure 6).  No effect of the combined treatment on luteal 
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morphology was evident in ovaries harvested from either the WT or SCARB1-/- mice (Figure 7).  
To further explore the means by which SCARB1-/- mice compensate for the deficiency in HDL 
uptake, we examined the abundance of signal for HMGR in the luteal structure in WT and 
SCARB1-/- mice by fluorescent immunohistochemistry and confocal microscopy.  The intensity 
of fluorescence indicates that HDL deficiency in SCARB1-/- mice results in increased expression 
of this enzyme (data not sowed).  Blockade of HMGR activity and concurrent interference with 
LDL metabolism had no apparent effect on the abundance of the HMGR cellular protein in the 
wild type mice.  In contrast, the expression of the cholesterol synthetic enzyme appeared more 
intense in the MEV-CHLORO treated SCARB1-/- mice.  This further supports the view that 
increased HMGR expression is a major mechanism by which SCARB1-/- mice obtain the 
cholesterol required for luteal steroid synthesis.   
DISCUSSION 
 The pattern of expression of SCARB1 in the mouse follicle differs from the other species 
where it has been examined in detail, the pig (Miranda-Jiménez et al. 2007), in that there is 
substantial signal present in the granulosa cells throughout the estrous cycle.  The protein 
localized to the cytoplasm and to the periphery of both granulosa and luteal cells in the mouse, in 
contrast to the pig findings, where there was a low level of punctate expression in the cytoplasm 
and primarily peripheral localization of the protein of the granulosa cells [9].  This difference 
may reflect, in part, differences in the method of detection, as, in another study, conventional 
microscopy demonstrated SCARB1 to be localized on the apical membrane of the enterocyte, 
while confocal microscopy revealed both cytoplasmic and membrane distribution [23].   
We further observed strong expression in the cumulus oophorus of the follicle, consistent 
with the view that the cumulus serves as an important source of cholesterol for the maturing 
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oocyte [24].  The distribution of the protein suggests SCARB1 may play an important role in 
uptake of HDL from the follicular fluid and consequent efflux to the oocyte.  The SCARB1-/- 
mouse, while capable of ovulation, is infertile, due to so far unexplained oocyte defects that 
prevent fertilization [12].  This infertility is reversed by transplant of the ovaries to the WT 
females [12], or by induction of hepatic SCARB1 expression in the liver alone [13].  These 
findings are consistent with the conclusion that dyslipidemia, and inappropriate transfer of HDL 
cholesterol between the cumulus cells and the oocyte impair normal oocyte development, 
thereby rendering the ovulated ovum not fertilizable.    
To explore the role of ovulation and luteinization in SCARB1 expression, we employed a 
pharmacological blockade of PTGS2, an enzyme well known to be necessary for the ovulatory 
process [25].  The qPCR results indicate that the process of SCARB1 expression in the ovary 
occurs in the absence of ovulation, and on a similar time scale.  Moreover, dynamics of SCARB1 
expression in relation to hCG injection were similar between treatments.  This is intriguing 
because, as observed in Experiment 1, CLs are the ovarian structures with greatest SCARB1 
expression, and they were present in a lower number in MEL-treated mice in all time points 
studied.  Fluorescent immunohistochemistry analysis permitted to observe a redistribution of the 
SCARB1 signal caused by MEL treatment.  Specifically, the SCARB1 signal became more 
intense in non-ovulated follicles in the MEL group, supporting the notion that such follicles 
luteinized. High expression of SCARB1 in non-ovulated, luteinized follicles probably accounted 
for less expression of luteal SCARB1 in MEL-treated mice.  The rare follicles that ovulated 
following MEL treatment appeared delayed in expression of SCARB1 suggesting that, in a few 
cases, the treatment retarded ovulation. 
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 Western analysis confirmed the absence of the SCARB1 protein in the SCARB1-/- mouse.  
In contrast to previous reports that indicate no differences in ovarian morphology between null 
and WT mice, and no reduction in circulating progesterone [11], our findings suggest significant 
pathology in the SCARB1-/- mouse ovary.  Corpora lutea were consistently smaller in diameter 
than those in WT animals.  There were large cystic, hemorrhagic follicles which resembled 
structures in mice with null mutation of the estrogen receptor- gene [26], suggesting that 
estrogen deficiency may play a role in the phenotype.  A further structure represented by an 
intact granulosa compartment surrounded by a hypertrophied theca was common in the ovaries 
of the SCARB-/- mouse.  The basis for this anomaly is unclear, but follicles with similar 
morphology can be found in a mouse model engineered to overexpress the luteinizing hormone-ß 
subunit [27].   
 We then examined the effects of reducing the availability of cholesterol by concurrent 
interdiction of de novo synthesis and interference with lyosomal processing of LDL.  This 
combined treatment had no apparent effect on the morphology of the ovaries, and reduced, but 
did not eliminate, circulating progesterone in both WT and SCARB-/- mice.  The increased 
expression of HMGR in the SCARB1-/- ovary was interpreted to be a feedback response to the 
reduction in intracellular cholesterol in the transgenic ovaries [28].  The mouse bearing 
spontaneous mutation in the Niemann-Pick C1 gene is unable to process LDL cholesterol but 
displays circulating progesterone concentrations that do not differ from WT mice [29].  The 
dysfunction of the LDL pathway is compensated, presumably by de novo synthesis of cholesterol 
and its importation via SCARB1.  As all three sources were compromised in the present study, it 
must be concluded that cholesterol stored in the CL in the form of cholestryl esters was the 
source of the substrate for progesterone synthesis.  
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 The feedback system for cholesterol homeostasis is regulated by the abundance of the 
transcriptionally active form of SREBP [28].  An important transcriptional target of SREBP is 
the HMGR gene, and evidence from the present investigation indicates that its expression is 
elevated in the SCARB1-/- mouse corpus luteum.  This concurs with the idea that inactivation of 
an import pathway, as occurs in the NPC-1 mutant mouse, is compensated by increased de novo 
cholesterol synthesis.  We saw an even greater expression of HMGR when there was interdiction 
of both the HDL and LDL import pathways.  It would appear that increased HMGR expression is 
a major alternative to supply cholesterol for luteal steroidogenesis.  
 In summary, we have shown an increasing, predominantly cytoplasmic SCARB1 protein 
expression in theca and granulosa cells in the mouse ovary during the final stages of follicle 
growth, with expression becoming maximal as follicular cells luteinize in response to the 
ovulatory stimulus.  Lack of a functional SCARB1 protein resulted in morphological aberrations 
of follicular structures in the ovary and reduction in progesterone synthesis.  Intraovarian 
cholesterol synthetic mechanisms can compensate, at least in the short term, for a non-functional 
cholesterol import system. 
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FIGURE LEGENDS  
Figure 1.  Protein expression of SCARB1 in mouse follicles during proestrus (panel A) and 
estrus (panel D) and in the corpus luteum (panel G) of mature mice undergoing normal estrous 
cycles. Panels A, D and G: confocal microscopy images of fluorescent immunohistochemistry 
staining of SCARB1; panels B, E and H: confocal microscopy images of DAPI staining of 
nuclei; panels C, F and I: merged image of SCARB1 and DAPI staining. The insert in panel G is 
a negative control for the SCARB1 fluorescent immunohistochemistry staining reaction. Bars: 
50mm. 
Figure 2.  Protein expression of SCARB1 in the ovarian theca (panel A), granulosa (panel B), 
cumulus oophorus (panel C) and luteal cells (panel D) of mature mice undergoing normal estrous 
cycles. Panels A, B, C and D are confocal microscopy images of fluorescent 
immunohistochemistry staining of SCARB1; panels E, F, G and H: confocal microscopy images 
of DAPI staining of nuclei; panels I, J, K, L: merged image of SCARB1 and DAPI stainings. 
Bars: 10mm. 
Figure 3.  Bright field microscopy images of hematoxylin-eosin stained sections of ovaries from 
immature mice stimulated with equine chorionic gonadotropin (eCG) and human chorionic 
gonadotropin (hCG) and collected 18 (panels A and D), 24 (panels B and E) or 36 h after hCG 
(panels C and F).  Mice received 0 (panels A, B and C) or 6 mg/g BW meloxicam, a 
prostaglandin synthase-2 activity inhibitor, (panels D, E and F). Bars: 150mm. 
Figure 4.  Relative abundance of SCARB1 mRNA (LSmeans  SEM) in the whole ovary of 
immature mice stimulated with PMSG and hCG and collected 18, 24 or 36 h after hCG as 
determined by qPCR.  Mice received 0 (Control; open bars) or 6 mg/g BW meloxicam, a 
cyclooxygenase-2 activity inhibitor (Meloxicam; solid bars). 
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Figure 5.  Protein expression of SCARB1 in the corpus luteum (panels A, B, C, G and H) and in 
follicles (panels D, E and F) of immature mice stimulated with eCG and hCG and collected 18 
(panels A and D), 24 (panels B, E and G) or 36 h after hCG (panels C, F and H).  Mice received 
0 (panels A, B and C) or 6 mg/g BW meloxicam, a prostaglandin synthase-2 activity inhibitor, 
(panels D through H). Merged confocal microscopy images of fluorescent 
immunohistochemistry staining of SCARB1 and DAPI staining of nuclei.  Bars: 50mm. 
Figure 6.  Plasma progesterone concentrations (LS means ± SD) from wild type (WT) or 
SCARB1-/- mature mice stimulated with eCG and hCG and collected 18 h after hCG.  Mice 
received placebo injections (Control) or a combination of 20 mg/g BW mevinolin (Mev; an 
HMGR inhibitor) and 100 mg/g BW chloroquine (Chloro; an inhibitor of lysosomal processing 
of LDL). 
Figure 7.  Bright field microscopy images of hematoxylin-eosin stained sections of ovaries from 
wild type (WT; panels A and C) or SCARB1-/- mature mice stimulated with eCG and hCG and 
collected 18 h after hCG.  Mice received placebo injections (panels A and B) or a combination of 
20 mg/g BW mevinolin (MEV; an HMGR inhibitor) and 100 mg/g BW chloroquine (CHLORO; 
an inhibitor of lysosomal processing of LDL; panels C and D). Bars: 200mm. 
Figure 8.  Bright field microscopy images of atypical structures in hematoxylin-eosin stained 
(panels A, B and C) or periodic acid-Schiff (PAS) stained (panel D) sections of ovaries from 
SCARB1-/- mature mice stimulated with eCG and hCG and collected 18 h after hCG.  Panel A: 
follicular cyst-like structure; bar: 200mm.  Panel B: small luteinized structure; bar: 100mm.  
Panel C: partially luteinized follicle; bar: 50mm.  Panel D: partially luteinized follicle showing 
intact basal membrane (arrow); bar: 50mm. 
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GENERAL DISCUSSION 
 
 Cellular cholesterol supply has been recognized as a fundamental need for adequate 
steroid production.  SR-BI, SR-BII, LDLR, and HMG-CoA-reductase, along with enzymes that 
esterify and liberate cholesteryl, are molecules that represent the principal mechanistic control of 
the cholesterol supply for steroidogenic cells. In the ovary, there are reports indicating that the 
receptors that import cholesterol and lipoproteins from which the cholesterol is derived depend 
on animal species (Murphy and Silavin 1989).  LDL has been reported as the most significant in 
lipoprotein in humans and pigs, while HDL as the main supply in species such as cattle and 
rodents.  This notwithstanding, studies in the rat suggested that, while SR-BI protein was present 
in the theca compartment, it was absent from the granulosa cells of ovarian follicles (Driancourt, 
Quesnel et al. 1998).  HMG-CoA is essential for de novo synthesis, but is not believed to supply 
sufficient cholesterol for adequate ovarian steroidogenesis.  A purpose of these studies was to 
explore the relative significance of cholesterol supply mechanisms to luteal steroidogenesis.  
Using the pig as animal model, we evaluated SR-BI expression in the follicle and the CL.  We 
concluded that SR-B1 is not an important transport mechanism in follicular granulosa cells, 
consistent with the view that the substrate for estrogen synthesis in these cells is androgens from 
the theca compartment of the follicle.  In contrast, our results demonstrate that, when cholesterol 
demand increases as luteinization ensues, the HDL receptor becomes highly expressed.  Our 
protein data concur with studies that show that increases in SR-BI mRNA abundance has been 
reported previously in the cow CL and attributed to the elevated steroidogenic activity of luteal 
tissue (Rajapaksha et al. 1997).  A new study of rhesus monkey luteinization following 
controlled ovarian stimulation demonstrates that SR-B1 mRNA abundance increases rapidly, 
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both in vitro and in vivo, during the first 24 h after treatment with hCG (Cherian-Shaw et al. 
2009).  In that study, in vitro protein abundance supports this finding, but concurrent increases in 
the LDL receptor are in contrast to our findings in the pig.  Further, Cherian-Shaw et al. (2009) 
demonstrate that both HDL and LDL support hCG-induced progesterone synthesis in rhesus 
granulosa cells early in the luteinization process (0-24 h after isolation of cells) while HDL is 
ineffective from 24-48 h.  At these later times, LDL continues to be a significant source of 
cholesterol to these otherwise substrate-limited cells.  This difference further confirms the idea 
that there are species differences in cholesterol supply to the corpus luteum (Murphy and Silavin 
1989). 
In chapter 1, we show that SR-BI exists predominately in the cytoplasm of granulosa 
cells.  Associated with ovulation, there appears to be post-transcriptional modification of SR-B1. 
This translocation was characterized by an apparent transformation of the 57 kDa to 82 kDa, the 
latter being the active (Cao et al. 2004), glycosylated form. Using enzymatic digestion of 
carbohydrates we confirmed that the difference between the 57 kDa and the 82 kDa protein in 
the pig, was in fact, the glycosylation.  The larger molecular weight form was twice as abundant 
in luteal cells when compared to granulosa cells, indicating that differentiation engenders an 
alteration in or upregulation of the glycosylation process.  This is at odds with the observation 
that N-glycosylated residues are co-translationally incorporated into the protein during its 
synthesis (Rigotti, Trigatti et al. 1997).  In pig granulosa cells, it appeared that SR-B1 localized 
primarily to the cytoplasm, with predominant expression at the cell periphery, and presumably 
the membrane in luteal cells.  This finding was not confirmed in the mouse, where confocal 
microscopy revealed abundant expression in the cytoplasm of the mouse luteal cells.  While this 
may be a species difference, it is also likely that it is attributable to increased sensitivity of the 
 115
confocal over traditional fluorescence microscopy.  Thus, determining whether post-
transcriptional changes in the SR-B1 molecule characterize luteinization requires further 
experimentation for clarification.  
Given that SR-B1 is strongly expressed in the CL, the second issue addressed in this 
thesis was whether ovulation was required to bring about its expression.  By 
immunocytochemistry, the occurrence and relative abundance of the SR-B1 signal was compared 
in the CL of immature mice induced to ovulate with a combination of eCG and hCG and allowed 
to ovulate with those treated with gonadotropins in which ovulation was blocked by inhibition of 
expression of COX-2.  The granulosa compartments of the ovaries in which ovulation was 
inhibited contained entrapped oocytes, and the mural cells took on a luteal phenotype as early as 
24 h after hCG administration.  The analysis by confocal microscopy, in which the microscopic 
parameters were held constant, indicated that there was no difference between expression in of 
SR-B1 between the luteinized follicle and the CL.  This was supported by the abundance of of 
SR-B1 in the ovaries as quantified by realtime PCR.  Thus, it would appear that the 
differentiation program that is initiated by the preovulatory surge does not require the actual 
extrusion of the oocyte to occur.  
To this point, our results have shown that SR-B1 is strongly expressed and characterizes 
luteal formation and function.  We then addressed the puzzle of how the SR-B1 deficient mouse 
can develop an apparently functional CL in the absence of this important cholesterol importing 
molecule, as indicated in the report by Trigatti et al. (1999).  Careful evaluation of mice with null 
mutation of the SR-B1 gene revealed that their assertion that luteal function is not different in 
mice in which this gene is disrupted is not correct.  Indeed, we show herein that circulating 
progesterone is reduced in the SR-B1 knockout animals, and that, in spite of the presence of CLs 
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in these mice, the ovaries contain a number of abnormal structures.  These include hemorrhagic 
follicles, a pathological condition frequently seen in knockout models in which estrogen 
synthesis is compromised (Ruiz-Cortez et al.  2005). In further experimentation, we attempted to 
eliminate two complementary sources of cholesterol substrate, de novo synthesis and LDL-
derived cholesterol.  To our surprise, these treatments had the effect of only reducing, but not 
eliminating circulating progesterone.  We blocked only the activity of HMGR, and 
immunocytochemistry strongly suggested that there was robust upregulation of the expression of 
the HMGR gene.  We did not have an adequate means of evaluation of LDL processing 
following chloroquinone treatment, and it is possible that this source of cholesterol was not 
entirely interdicted.  The only major means to supply cholesterol that remains is liberation of  
stored cholesteryl esters.  Total ovarian storage of cholesterol is reduced in the SR-B1 knockout 
mouse (Fenske et al. 2008) but our results suggest that a sufficient amount is present to allow for 
progesterone synthesis, albeit at a reduced level. 
The SR-B1 homozygous null mice are infertile, but this infertility is not directly 
attributable to luteal dysfunction, rather, it appears to be due to oocyte defects.  Recently this 
infertility has been reported as a consequence of dislipidemia  which may be resolved through 
SR-BI repletion at hepatic level (Yesilaltay et al. 2006).  This suggests that, HDL particle size 
may be associated with this phenomenon.  The mechanism by which inappropriate oocyte 
development occurs remains a mystery.  Recent reports indicate that oocytes outsource metabolic 
functions, including the acquisition of cholesterol via SR-B1 (Su et al. 2009) 
 In overview, this thesis has shown the importance of SR-B1 in luteal function.  This was 
first, by demonstration of its differential expression between the follicular and luteal phase in the 
pig.  Studies in the mouse concurred in general with the distribution and expression patterns in 
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the pig ovary.  Knockout of SR-B1 compromised but did not completely disrupt luteal function, 
providing further indication of the significance of this molecule in supply of cholesterol for luteal 
steroidogenesis.  Further work could focus on determining the mechanism of cholesterol transfer 
to the oocyte, to resolve the issue of SR-B1 in fertility.  
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